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ABSTRACT 
ABSTRACT 
For decades, the monitoring of mixed venous oxygen saturation has been done 
invasively using fibre-optic catheters. This procedure is not without risk as 
complications may arise from catheterization. This thesis describes an alternative and 
novel means of monitoring venous oxygen saturation. The technique outlined involves 
inducing regular modulations of the venous blood volume and the associated 
measurement of those modulations using an optical sensor. Just as pulse oximetry 
utilizes the natural arterial pulse to perform spectral analysis of the peripheral blood in 
order to estimate the arterial blood oxygen saturation, the new venous oximetry 
technique uses the artificially generated pulse to perform the task of measuring 
peripheral venous oxygen saturation. 
This thesis explores and investigates the feasibility of this new venous oximetry 
technique. A heuristic model was first developed to predict the effects of introducing 
an artificially generated pulsatile signal in the venous system. The effect on the 
underlying natural arterial pulsation was also examined. Experiments were then 
conducted to justify and interpret the model developed. Other experiments were also 
conducted to optimize the design of the artificial pulse-based venous oximeter, to 
explore the effects of prolonged modulation of the venous system and to establish 
evidence that the measurements made were indeed related to venous oxygen 
saturation. 
It is concluded that the new venous oximetry technique is indeed feasible and with 
further research and development would one day replace the current invasive method. 
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INTRODUCTION 
1. INTRODUCTION 
Venous oximetry or venous oxygen saturation monitoring is an essential tool 
for assessing the patient's oxygenation both at the systemic and regional 
levels. It is also used to derive other hemodynamic parameters indirectly, 
such as Cardiac Output (CO) measurement through the Fick method. 
Although the technology involved in venous oximetry has been around for 
decades, venous oximetry is still not widely adopted as the end point in 
guiding therapy. Currently, one of the main disadvantages of the venous 
oxygen saturation monitoring technique is the invasive nature of the method. 
In order for progress to be made in the field, it is postulated that a new non- 
invasive method is needed to supplant the current technique to help venous 
oximetry with achieving its optimal clinical impact. 
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1.1 THESIS OVERVIEW 
Venous oximetry has been noted for decades to potentially be of clinical value in the 
assessment of oxygenation. One of the main obstacles in limiting the wide application 
of venous oximetry in clinical environments is the invasive nature of the method. In 
view of the limitation in the present venous oximetry technology, it is the aim of this 
thesis to explore the possibility of developing a new non-invasive method that is able 
to monitor venous oxygen saturation in real time. This new technology would result in 
a more acceptable and risk free technique for monitoring venous oxygen saturation. 
The first chapter begins by introducing the importance of oxygen to the human body; 
on how the limited reserve we have in our body requires us to have a continuous input 
through breathing. The physiological aspect of how oxygen is transported to various 
parts of the body where it is needed will also be discussed briefly. A brief synopsis on 
the history of oximetry and the various techniques that are currently available will 
also be included. Lastly, there will be an introduction to photoplethysmography (PPG) 
and pulse oximeter (since they are closely related to the new proposed method). 
Chapter 2 will be devoted to the mathematical modelling of the introduction of an 
artificial venous pulsation to the venous system. The new venous oximetry 
mathematical model will describe both the PPG signal and the induced artificial 
pulsatile signal of the vascular system. A heuristic PPG model developed by 
SmithHayes (upon which the new method is based) will also be presented here. This 
chapter will also discuss the effects of introducing an artificial pulsatile signal into the 
vascular system from the heuristic model's perspective and the nature of the active 
pulse in its relation to the underlying PPG signal. The multiplicative ten-n derived 
from the model is the measure of the degree of coupling between the two signals and 
this will also be examined closely. Finally, a discussion of how the model can be 
modified to interpret venous oxygen saturation will also be included. 
Chapter 3 discusses the implementation of the new non-invasive and continuous 
venous oximetry technique. Emphasis will be placed on the theoretical and practical 
issues affecting the overall performance. The chapter will provide an overview of the 
electronic implementation of the new technique in venous oximetry. 
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It will also include an introduction to the software required to control the hardware 
and to coordinate data acquisition. 
In chapter 4, experiments that were conducted to investigate the feasibility of the new 
method in measuring venous oxygen saturation will be outlined, followed by 
discussions on the experimental results. Some of the investigations that will be 
described are the experimental justification of the heuristic model, the optimisation of 
the design and the verification of the measurements taken as truly related to venous 
oxygen saturation. The protocol of the experiments and the data analysis that followed 
will be described in detail. Finally, a discussion of the results and its implications will 
also be included. 
Chapter 5 briefly reiterates the major achievements of the work and provides 
concluding remarks. Recommendations are also made for further studies in this area. 
The references are collected in a common section following the main body of the 
report. Appendices are included, which offers technical details about the electronic 
design of the new method of venous oximetry and the program listings used for 
conducting the experiments. 
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1.2 IMPORTANCE OF OXYGEN TO THE HUMAN BODY 
Hippocrates (460-377 B. C. ) suggested that the purpose of respiration was to cool the 
heart. However, it is unequivocally established that the main purpose of respiration is 
to supply oxygen; 02 to cells for their metabolic needs and to remove carbon dioxide 
(C02) from cells. Living cells need energy for maintenance, growth, defence and 
replication. The energy required to facilitate this process is obtained through aerobic 
respiration. This is a process that requires oxygen and produces carbon dioxide. 
Food, water, and air constitute the essentials of life. Energy derived from the 
oxidation of food can be used immediately or it can be stored in high energy chemical 
bonds for later use. A readily available energy supply is required both for physical 
activity and, more importantly, to maintain order and to keep the organism displaced 
from equilibrium or death. However, the ability of the organism to store these 
essentials varies considerably. For example, humans can survive for weeks without 
the intake of food; this suggests that the body has relatively large energy stores or 
reserves. Human beings can also survive for days without water or H20; suggesting 
the body has considerable water reserves. However, human beings can survive for 
only a few minutes without air or02. This indicates that life is dependent on the 
minute-to-minute transfer of air (02) from the environment to the tissue cells. This 
also indicates that, unlike energy (food) or H20, human beings have relatively little 
storage capacity or reserve0f 02in the body. 
1.2.1 Oxygen Transport 
In order to illustrate the role of both venous and arterial blood in the transportation of 
oxygen, it helps to look at how gaseous exchange is achieved through respiration. The 
lung is mobilized by contractions of respiratory muscles, which create a pressure 
gradient to move02 from the atmosphere to the gas exchange sites within the lungs. 
Airways and alveoli of the lung comprise the conduits that direct gas from the 
atmosphere to the blood. From the alveoli, oxygen diffuses into the blood and the 
cardiovascular (C-V) system then transports02 from the lung to the cells of the body 
(tissues). 
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Therefore, there is an interdependence of the pulmonary and cardiovascular system in 
delivering02 to and removingC02 from cells of the body. The interdependence is 
illustrated in the figure below: - 
ý771 
Left 
heart 
02 
Gas 
Lungs exchange 
C02 Right at tissue 
heart level 
Figure 1.1 - The anatomical design of respiration. 
The blood delivered by the pulmonary arteries has a higher level of carbon dioxide 
partial pressure (PC02) and a lower level of oxygen partial pressure W02) than 
alveolar air. Diffusion between the alveolar air and the pulmonary capillaries thus 
elevates the P02 of the blood as oxygen enters the bloodstream whilst lowering its 
PC02 as carbon dioxide leaves it. 
1.2.1a The Human Cardiovascular System 
In the human cardiovascular system, the arteries and veins serve as conduits for 
delivering nutrients and oxygen (02) to cells far removed from the source, whilst 
simultaneously removing and transporting waste and carbon dioxide (C02) from the 
immediate area of the cells to organs designed to eliminate them from the body. An 
illustration of the human body cardiovascular system is shown in Figure 1.2. 
The oxygenated blood is carried back to the heart (left atrium) through the pulmonary 
veins and is emptied into the left ventricle during diastole. Oxygenated blood is then 
pumped into the arterial system during systole; that is, when the left ventricle 
contracts. 
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The arteries serve as conduits to transport blood and thus, oxygen from the heart to 
peripheral vessels (arterioles and capillaries). In this way, oxygen is being transported 
to various parts of the body where it is needed. Arterioles are short vessels composed 
almost exclusively of smooth muscle. They serve as "stopcocks" or valves that 
regulate the flow of blood from arteries to capillary beds. The vessels can redistribute 
flow by constricting or dilating; thus increasing flow to tissues undergoing high levels 
of activity (exercise) and reducing flow to areas where less flow is needed. 
The capillaries are short, thin-walled vessels that provide a large total cross-sectional 
area (considering all capillaries as a unit) for exchange of materials with interstitial 
fluid and cells. Normal interstitial fluid has a oxygen partial pressure (P02) of 40 mm 
Hg and a carbon dioxide partial pressure (PC02) of 45 mm Hg. As a result, oxygen 
diffuses out of the capillaries and carbon dioxide diffuses in until the capillaries' 
partial pressures are the same as those found in the adjacent tissues. Venules are low- 
pressure vessels that collect blood from capillaries and return it to the veins. The 
blood is then transported to the heart. 
Figure 1.2 - Human cardiovascular system 
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1-2.1b The Binding of Oxygen to Hemoglobin Molecules 
Only 1.5 percent of the oxygen content of arterial blood consists of oxygen molecules 
in solution. The remaining oxygen content of arterial blood is bound to the 
hemoglobin (Hb) molecules and specifically to the iron atoms in the centre of heme 
units. This reversible reaction can be summarised as follows: 
LTL+O 
nu 2 <--> Hb02 
1.2.1c The Release of Oxygen into Tissues 
The amount of oxygen retained by hemoglobin depends primarily on the P02 in its 
surroundings. As a result, the lower the oxygen content of a tissue, the more oxygen is 
released by hemoglobin molecules as they circulate through the region. At a normal 
tissue P02 of 40 mm Hg, hemoglobin releases approximately 25 percent of its stored 
oxygen. Active tissues consume oxygen at an accelerated rate. When P02 declines, it 
automatically increases the amount of oxygen released by hemoglobin molecules 
passing through local capillaries. In addition to the effect Of P02, the amount of 
oxygen released is also influenced by pH and temperature. The hemoglobin molecules 
release their bound oxygen molecules more readily when the pH declines. 
Hemoglobin also releases more oxygen when the temperature rises. 
1.3 INTRODUCTION TO VENOUS OXIMETRY 
Venous oximetry refers to the range of techniques that are employed to measure the 
oxygen saturation in the venous blood. It can be further divided into two categories; 
mixed venous oxygen saturation (SV02) and peripheral oxygen saturation. Mixed 
venous oxygen saturation (SV02) is a reflection of the body's total oxygen 
consumption, or the end result of both oxygen delivery and consumption at the tissue 
level. Peripheral oxygen saturation is the measure of oxygen saturation in specific 
regions of the human body, such as the forearm or cerebral oxygenation in the brain. 
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PrincipleOfSV02Monitoring 
SV02monitoring is based on the premise that hemoglobin releases oxygen to the cells 
in a manner which is dependent on the cellular need for oxygen and the amount of 
oxygen that is being delivered. As discussed in the previous section, hemoglobin can 
unload oxygen and allow the cells to extract oxygen from the blood. It is dependent 
upon cellular oxygen demand and partial pressures of oxygen, as shown in Figure 1.3. 
As the cells unload oxygen, hemoglobin desaturates according to cellular oxygen 
requirement, as illustrated in Figure 1.4. 
cells Capillary 
Arterioles 
IF 
Hgb 
Four 02 
Hgb molecules bound 
to each'Hgb 
>Interstitial 
space / molecule 
Saturation 
of Hgb - 95% 
P02 -I 00mm Hg 
Figure 1.3 - Saturation of hemoglobin on arrival to the cells 
Cells required 4 
Molecules of 02 t Hgb 
Hgb Hgb 
Saturation 
Of Hgb - 75% 
P02 - 40mm Hg 
Figure 1.4 - Desaturation of hemoglobin at the cellular level 
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The desaturation of hemoglobin is never complete; that is, hemoglobin never releases 
all of its oxygen. Under normal circumstances, hemoglobin releases approximately 
one fourth of the oxygen attached to hemoglobin, releasing enough for cellular need 
and resulting in a normal venous oxygen saturation of approximately 75%. If oxygen 
delivery is inadequate or cellular demand increases, hemoglobin carries a reserve of 
oxygen in the sense that approximately 40-50% more oxygen can be extracted off 
hemoglobiný11. Generally speaking, hemoglobin can never totally release all of the 
oxygen content attached to hemoglobin molecules, but can release levels up to nearly 
70- 80%ý21 . This equates to a mixed venous oxygen saturation of about 
20-30%. The 
only oxygen reserve that is truly present in the body is hemoglobin's ability to release 
more oxygen than the 25% that is released during a normal oxygen pass by the 
tissues. If the cells require more oxygen, hemoglobin can release more, which would 
result in a decreased venous oxygen saturation level. 
1.3.2 Mixed Venous Oxygen Saturation (SV02) 
Mixed Venous Oxygen Saturation or SV02monitoring is the measurement of the 
amount of oxyhemoglobin returning to the lungs after all tissues have extracted the 
required oxygen [3] . Normally, 
SV02 levels are obtained from the pulmonary artery. 
This allows for a mixing of blood ftom all parts of the body to reveal a mixed sample 
of oxygen in the blood. The SV02 level is determined by various factors, namely 
oxygen delivery or D02 (CO- Cardiac Output, hemoglobin, arterial oxyhemoglobin 
and arterial oxygen tension) and oxygen consumption (V02). Oxygen consumption 
can be defined as the amount of oxygen consumed by the body and is related to 
cardiac output, the oxygen carrying capacity of the blood, the amount of exercising 
skeletal muscle and the ability of the muscle to utilise supplied oxygen. The 
relationship can be expressed in the following modified Fick equation: 
SV02 
- Sa02- 
V02 
'***********'***'*********'***'****'**' 
1.2 
1.306 x CO x Hb 
Where Sa02 is the arterial oxygen saturation, Hb is the hemoglobin concentration and 
1.306 is the oxygen combining power of hemoglobin 
[41 
. 
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The SV02 level is also a reflection of the balance between oxygen delivery and 
utilisation. It is also a good indicator of the overall cardiopulmonary system. Since it 
consists of a mixture of blood returning to the lungs, SV02 is a global reflector of 
tissue oxygenation. 
AlthoughSV02values do not reflect a change in any single component of 
D02 or V02 
(unless all other components are held constant), SV02 values do however, reflect 
when an imbalance in D02 andV02 exists. When such an imbalance occurs, 
SV02 
[5] 
values change rapidly to reflect this imbalance 
Under normal conditions, the SV02 is 68% to 77%, indicating that the tissues will 
extract approximately 25% of the oxygen delivered. An increase in theV02 or a 
decrease in the arterial oxygen content (Sa02 x Hb) is compensated for by increasing 
the cardiac output or tissue oxygen extraction. 
A normal SV02 however, does not ensure a normal metabolic state. In certain 
situations, a non-nal SV02may be present due to regional hypoperfusion, left-to-right 
systemic shunts, or poisoned mitochondria from cyanide poisoning 
[6] 
. However, 
SV02 
is the best single measurement to use in assessing the overall adequacy of 
oxygenation in the critically ill patient. 
1.3.3 Peripheral Venous Oxygen Saturation 
Peripheral venous oxygen saturation monitoring is mostly done on specific regions of 
the human body such as in the adult human forearm [7] . The availability of oxygen to 
the peripheral tissues in animal models of shock and in critically ill adults have been 
studied by measuring tissue P02 
[8] 
. These studies 
have shown that the measurement of 
peripheral oxygenation is a sensitive method of studying the progress of shock and 
resuscitation. Peripheral oxygen saturation or tissue oximetry (in conjunction with 
various exercise protocols) have an application in the diagnosis of peripheral vascular 
disease[9]. 
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Specialised. algorithms have also been developed to allow the assessment of muscle 
oxygenation and regional blood flow during submaximal and maximal exercise, as 
well as under other pathophysiological conditions including cardiovascular disease 
[10] and sepsis 
1.3.4 The Importance of Venous Oximetry 
As there is currently no gold standard available for the measurement of tissue 
oxygenation, traditional assessments of the adequacy of oxygenation have relied on 
parameters such as blood pressure (13P), cardiac output (CO) and physical assessment. 
However, several studies have shown that these traditional assessments are limited"'. 
Furthermore, traditional hemodynamics such as BP, cannot reflect tissue oxygenation 
reliably and are not the best physiological parameters for assessing the impact of 
therapy 
[12] 
SV02 overcomes these traditional assessment limitations by offering the following 
advantages: - 
eA rapid, virtually immediate, indicator of a threat to global tissue oxygenation. It 
detects the threat by noting an increase in oxygen extraction from hemoglobin. 
1. It replaces BP and CO as the initial indicators for the adequacy of blood flow 
to the tissues. 
2. It indicates at what point parameters affecting oxygen delivery and 
consumption causes a threat to tissue oxygenation. 
3. When used in conjunction with lactate, it indicates the severity of the threat to 
tissue oxygenation. 
9 It allows for the real time measurement of intrapulmonary shunting. 
9 It helps to correctly attribute changes of arterial oxygenation to intrapulmonary 
shunting or tissue oxygenation. 
9 It detects changes in oxygen consumption during weaning, movement and 
sedation control. 
SV02 has been indicated as a prognostic indicator, such as in the case of patient 
131 
with congestive heart failure (CHF)ý 
CHAPTER III 
INTRODUCTION 
Considering these advantages and its indication of the threat to tissue oxygenation 
which is unmatched by other parameters, venous oximetry is fast becoming an 
indispensable tool in the area of medical diagnosis. Its ability to give a real time 
indication of tissue oxygenation makes it a preferred parameter for monitoring the 
adequacy of hemodynamics. Its use as an end point for determining the adequacy of 
hemodynamics, measurement of intrapulmonary shunting and prediction of potential 
hemodynamic instability, make this parameter invaluable for the knowledgeable 
clinician. Used in context with the complete physiological profile, SV02 is helping to 
revolutionise our understanding of tissue oxygenation and our related patient 
management [14] . There are no 'short cuts' to critical care, 
but SV02monitoring may 
represent the best alternative that is currently available. 
1.4 INTRODUCTION TO VENOUS OXIMETRYTECHNIQUES 
All venous oximetry techniques can be categorised into two areas; methods that are 
invasive and those that are non-invasive. Each area is further divided into continuous 
and non-continuous. The differences are illustrated in Figure 1.5. Among the first 
method available is that of a blood gas analyser. A sample of pulmonary artery blood 
is taken and then analysed for its oxygen saturation in a blood gas analyser. However, 
the invasive nature of the measurement and its lack of real time monitoring capability 
limit its usefulness in the clinical environment. 
Venous Oximetry 
'Arý 
Invasive 
Continuous Non-continuous 
Non-invasive 
Continuous Non-continuous 
Figure 1.5 - Different types of venous oximetry techniques 
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1.4.1 Continuous Invasive Venous Oximetry Method 
Invasive continuous mixed venous oxygen saturation (SV02) monitoring is a 
technique that has been in existence for about 25 years [151 . The technique 
is a variation 
of the standard Swan-Ganz Pulmonary Artery Catheter (PAC). The PAC was 
introduced in the 1960s and became a standard by the 1970s. The second variation of 
the technique arrived in the early 1970s and evolved to become a standard in the 
1980s. The PAC is used within the Intensive Therapy Unit (ITU) for various 
diagnostic purposes such as to evaluate heart failure, monitor therapy after a heart 
attack, check the fluid balance of a patient with serious bums, kidney disease or after 
heart surgery. 
After receiving a local anaesthetic, the catheter is placed through the skin into a vein. 
This can be a vein under the collar bone, a vein in the neck, a vein in the arm or in the 
leg. The catheter is essentially a long, thin plastic tube that contains multiple channels 
within it. The catheter is then advanced through the vein, through the right sided heart 
chambers and into the pulmonary artery. It is usually left in place for I to 3 days, 
depending on the patient's clinical situation. It gives valuable information about the 
pumping ability of the heart and the pressure within the chambers of the heart which 
can help to guide further therapy. 
In the late 1980s, two fibre-optic bundles were inserted in the PAC. This permitted the 
transmission of a light to the tip of the catheter in the pulmonary artery via one of 
these two fibre-optic bundles. The second bundle was used to reflect back the redness 
seen with this light into a photodetector cell. The redness of the light could then be 
translated into mixed venous oxygen saturation (SV02), thus providing a clinician 
with a quantitative measurement of oxygen transport. This instrument used the 
principle of reflection spectrophotometry to make this measurement. This modified 
PAC wa s slow to become popular and is still not used in all hemodynamic 
monitoring, despite SV02 being rather valuable in its ability to make judgements 
about the balance of total body oxygen supply and demand. The modified PAC was 
then named SV02 catheters. A sketch of a 
SV02 fiber optic catheter is shown on 
Figure 1.7. 
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Figure 1.6 - Sketch of aSV02fibre optic catheter 
Central Venous Cathetherization (CVC) is a variation of the PAC technique. This 
method is sometimes preferred because it is relatively less risky and costly than PAC. 
In CVC, the catheter is inserted into the large veins and the tip of the catheter is 
advanced into the superior vena cava (SVC) which is more accessible than the 
Pulmonary artery (Figure 1.7). 
catheter enters 
catheter tunnels under 
cental line catheter-; O-pw/ 
Figure 1.7 - Insertion of Central venous catheter. 
There are currently studies being made on whether the venous oxygen saturation 
measurement obtained using these two methods are interchangeable. in one of the 
studies by Ladakis et aL, it was found thatSV02 can be estimated with great accuracy 
by central venous oxygen saturation 
(SCV02) using a power modd 
16] 
. However, a 
[17,18] 
separate study observed a poor correlation betweenSCV02andSVO2 
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Until further studies could be made to compare the two variants of the technique, 
mixed venous oxygen saturation monitoring through Central Venous Catheterization 
remains a questionable alternative. 
1.4. la LimitationsOf SV02and Central Venous Catheters 
Although the new technology offers real time monitoring capability, it is more limited 
than laboratory measurements that are obtained by co-oximetry. One key limitation of 
the two-wavelength system is the potential to have elements in the blood other than 
oxyhemoglobin and reduced hemoglobin reflect light. For example, the presence of 
excess lipids or dye can alter the SV02 signalý191. This limitation of the two- 
wavelength system was finally addressed when Baxter improved the optical 
processing method of the system and several studies now support its accuracy [20] . 
The primary concern now, with the two-wavelength system, is its inability to control 
and account for hemoglobin changes. Changes of more than 2 g/dL (grams/decilitre) 
would cause the two-wavelength system to be suspect in accuracy. However, current 
literature does not appear to identify or support this concern. 
The cost of special SV02 catheters has been a controversial issue in clinical care. A 
special fibre-optic SV02 catheter cost about E66 more than a nonnal PAC catheter 
(f I 10 versus f44) and as such, clinicians are not in agreement as to the cost-benefit 
and the cost-effectiveness of theSV02 catheter. As a result, SV02monitoring utilising 
a fibre-optic catheter is not widely adopted in ITU. 
Another limitation of the present invasive method of venous oxygen saturation 
monitoring is that the time needed to set up the catheterization might not be suitable 
for patients in critical conditions where an immediate assessment of venous oxygen 
saturation is needed. A non-invasive SV02 monitoring device would be useful in 
ambulatory settings as it allows SV02 assessment without the need for pulmonary 
catheterization. 
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Research does support howSV02monitoring allows more rapid ten-nination of drug 
therapies, reduces the incidence of mechanical ventilator manipulation and may 
improve the movement of patients out of Intensive Therapy Units. What is needed in 
place of this present invasive method, is a system which is non-invasive; one that 
would negate the complications that might arise with Pulmonary Artery 
Catheterization and a method that could provide an immediate assessmentOf SV02- 
1.4.2 Continuous Non-invasive Venous Oximetry Method 
Near Infrared Spectroscopy (NIRS) is a relatively new venous oximetry technique and 
has shown much promise, as evident in the vast literature on its applications. The first 
observations using MRS were made by Mbsis (1977). Subsequently, the technique 
has been refined and applied to the study of cerebral hemodynamics in new born 
[211 [22] [231 babies , children as well as adults 
In NIRS, the light emitted by appropriate sources (typically laser diodes), at 
wavelengths in the range of 650-900nm, is conveyed to the skin of the subject. Whilst 
[24] 
propagating through the tissues, the light undergoes both scattering and absorption 
Scattering is due to the discontinuities in the refractive index, which typically take 
place at the membranes and organelles. The optical absorption is generally due to a 
large number of substances present in the tissues. In near infrared, the dominant 
species are water, cytochrome a and a3, myoglobin and hemoglobin in its oxygenated 
and reduced forms. Between the wavelength of 700-850mu, the absorption is mostly 
due to oxyhemoglobin and deoxyhemoglobin. After travelling through the tissues, 
part of the light would be diffusely reflected from the skin and can be detected at a 
distance from the source. The spacing between the source and the detector is known 
as optrode spacing. Increasing the optrode spacing improves the sensitivity. However, 
in order to achieve a sufficiently high signal-to-noise ratio, it was necessary to limit 
[251 this distance 
Specific algorithms have been developed to calculate the concentration changes of the 
species. Algorithms that involve using three wavelengths and solving three 
simultaneous equations 
[26] 
will be highlighted here. 
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MRS is based on a modified version of the Beer-Lambert law. The Beer-Lambert law 
(or Beer's law) is the linear relationship between the absorbance and the concentration 
of an absorbing species. The general Beer-Lambert law is usually written as: 
A =, u(A)rC ......................................................................... 
1.3 
where A is the measured absorbance, p(A) is a wavelength-dependent absorptivity 
coefficient measured in L mol-lcm-1, r is the path length measure in cm, and C is the 
analyte concentration in mol L-1. Changes in the concentrations of the three different 
species (or chromophores) can be measured from changes in the absorbance of light 
transmitted into the tissues, using a modified Beer-Lambert law, the following can be 
derived: 
A= p(A)xrxCxG .............................................................. 
1.4 
The addition of G is used to accommodate the tissue properties and it varies with the 
type of tissues and geometry of the optrode positioning. G is also known as the path 
length modifier. By assuming that G, r and p(A) are constants, changes in the 
absorbance of light should only be due to: 
A. A =Ix p(A) x AC ............................................................... 
1.5 
Where we made the substitution, I= rxG. There are three different chromophores 
involved; oxyhemoglobin (Hb02), deoxyhemoglobin (Hb) and cytochrome a3 (0). 
By assuming that the absorption at each wavelength is a linear summation of the 
effects of these 3 compounds then: 
A(Aj 
= pHb 
(An ) CHb +p Hb02 (Iln)CHbo2 + , a3 (A 
n)Ca3 ....................... 1.6 1 
Where A(A, ) is absorption measurement at wavelength n, '( is absor tion P 
An) p 
coefficient of compound x at wavelength n and C, is concentration of compound x. 
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In order to calculate the change in concentration of the three chromophores, three 
different light sources were used to measure the absorption changes such that three 
simultaneous equations can be constructed. By doing a matrix inversion, a 
multiplying factor, a, for each wavelength and compound is then obtained. The 
concentration changes are then calculated as: 
CHb 07 
Hb (ýj O-Hb (112 O-Hb (, Z3 
1 CHbO2 a HbO2 o7'02 (/ý) ullbO2 .................... 
1.7 
Ca3 07 a3 (/ý -a3 (, Z2 , a3 (/ý) 
The calculated concentration changes are then expressed in mol L-1 multiplied by the 
optical path length, 1. For example, for oxyhemoglobin: 
1*cHbO2 = 07Hbo2 (1ý)A(1ý) + o-HbO2 (1ý)A(A2 )+ o-Hbo2 (23)A(/ý) ............... 1.8 
The algorithm was used to calculate cerebral oxygenation. The results can also be 
related to venous oxygen saturation when used in conjunction with other protocols. 
1.4.2a Limitations of MRS 
Applications of the modified Beer-Lambert law to living tissues are difficult because 
the optical path length cannot be determined precisely 
[27] 
. The means of determining 
the optical path length remains problematic in MRS and presently, the problem is 
attempted by time-of-flight and phase modulation of the light source. The factor, G in 
the modified Beer-Lambert model is not constant for all subjects as it varies with 
different skin types. Furthermore the method is very sensitive to blood flow. These 
factors greatly affect the calibration of the instrument for venous oximetry. 
MRS is currently not widely used in clinical environments for measuring venous 
blood oxygen saturation. It is generally considered more as a research equipment. 
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It is hoped that the development of MRS would one day provide information on 
regional and global cerebral oxygenation, as well as total cerebral blood volume by 
measuring changes in total Hb over time. 
Due to its limitation, MRS is a poor candidate to replace the traditional method of 
venous oximetry usingSV02and central venous catheters. 
The proposed new method of venous oximetry is closely related to plethysmography 
and pulse oximetry. The rest of this chapter will be devoted to both of these topics as 
they are crucial to understanding the new proposed method of venous oximetry. 
1.5 INTRODUCTION TO PHOTOPLETHYSIVIOGRAPHY 
[28] 
Photoplethysmography (PPG), which was developed by Hertzman in 1938 , is the 
electro-optic technique for the non-invasive monitoring of peripheral blood volume 
changes. It is a simple and useful method of measuring the cardiovascular pulse wave 
found throughout the body, which is caused by the periodic pulsations of arterial 
blood volume and is measured by the changing optical absorption which this induces. 
Clinicians have since used the PPG for diverse applications when there are questions 
arising out of changes in blood volume, blood pulsatility and tissue perfusion by 
blood. 
The ease of use, simplicity and non-invasive nature of the technique has resulted in 
the dominance of the optical methods as the preferred technology in a number of 
biomedical monitoring situations. The introductory notes here will briefly explain the 
basic principles of the operation of PPG systems and its current major applications. 
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1.5.1 Principle of Operation 
Photoplethysmography [291 refers to optical plethysmography (the registration of blood 
volume change), and was originally used to describe the electro-optic technique of 
measuring the cardiovascular pulse wave. The pulse wave is discernible by the 
dynamic optical absorption that the periodic arterial pulsations induce in well- 
perfused peripheral tissues. 
1.5.1a Transmission and reflection modes 
PPG signals could be observed by illuminating a suitable pulsating vascular bed; for 
example, by trans-illumination of the fingers or toes. The most commonly used light 
source is Infrared light since it is well absorbed in blood and weakly absorbed in 
tissue. This property of Infrared light causes the pulse wave to be observed in 
reasonable contrast. As the illuminated vascular bed pulsates, the optical path length 
through it alters and therefore the transmitted light is modulated throughout the 
cardiac cycle. This transmission mode PPG is limited to monitoring sites that are 
well-perfused and sufficiently transparent for the transmitted light to be detected 
(such as the finger tips, toes, ear lopes and in the case of infants, the foot or palm of 
the hand). 
In reflection mode PPG, both the source and detector are positioned at the skin surface 
as shown in Figure 1.8, with back scattering light returning from a range of depths 
within the highly scattering tissue. 
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Figure 1.8 - Reflection mode PPG, source and detector placement. 
In the near infrared region, light penetrates several centimetres into tissues [30] , where 
the dynamic absorption of the pulsating vascular bed modulates the total reflected 
light. Reflectance PPG enables monitoring on other peripheral sites such as the 
[3 1] forehead, limbs and chest . 
1.5. Ib PPG Signal Components 
PPG systems differentiate between light absorption due to blood volume and that of 
other fluids and tissue constituents by observing that arterial blood flow pulsates 
whilst tissue absorption remains static. There are therefore two components in the 
PPG signal; the rapidly alternating signal (AC component) which is caused by the 
arterial pulsations and the steady signal (DC component) due to other fluid 
constituents, together with bone and tissues which do not modulate the light but have 
a fixed level of absorption. The pulsatile component accounts for a small proportion 
(I - 5%) of the total intensity 
[32] 
. The small arterial 
blood volume changes will induce 
a parallel change in optical path length and also function to modulate the macroscopic 
absorption of the vascular bed (Figure 1.9). 
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Figure 1.9 - Dynamic absorption of vascular bed 
The arterial pulse amplitude has been physiologically interpreted as the measure of 
(33] 
the blood supply to the skin . 
Since blood circulation in the body undergoes a 
transition from high-pressure arteries to low-pressure veins, much of the non-pulsatile 
blood will be venous. This non-pulsatile intensity has been found to be useful in 
comparative venous testing [34-36] . 
Any PPG realisation will consist of both the AC and 
the DC signal. The former being the dynamic component representing the arterial 
pulsations and the latter being the slowly, changing quasi-static component, which is 
indicative of the venous blood volume. 
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1.5.1c The PPG Waveform 
Although it is an implicit assumption that in PPG, changes in measured light intensity 
are due to changes in blood volume, no direct relationship has been formulated 
between the observed pulsations and the underlying physiological dynamics. 
However, a significant correlation has been reported between dynamic (AC) PPG 
signal and strain-gauge plethysmography [371 . The over simplistic 
Beer-Lambert law of 
optical transmission through tissue is often employed to aid physical 
understanding[38] , with 
broader theoretical applicability afforded by the diffusion 
[39,40] theory . Whilst the received light intensity depends on many 
factors (both 
physiological and geometric), appropriate sensor designs coupled with compensation 
for skin absorption by control of the source intensity [41] can result in a quasi-static 
(DC) PPG signal which is governed to a large extent by the total illuminated blood 
volume. Dynamic changes in the optical properties of the tissue, such as the arterial 
pulsations, can be further used to isolate absorption by dynamic blood from 
absorption by static blood. In this way, non-invasive characterisation of blood may be 
performed despite the complex optical interactions and the inherent variability in both 
subjects and geometry. 
Analysis of the PPG waveform. can be used to infer physiological information. For 
example, the presence of a second, smaller pulse within the arterial pulse called a 
dichrotic notch (Figure 1.10) is due to the pressure wave reflection from the lower 
[42,43] 
body at the bifurcations of the arterial tree 
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Studies have shown that the dichrotic notch slowly disappears from the PPG 
waveform with age. This has been explained by reduced wave reflection 
[44] 
. The 
dichrotic notch is the most noticeable feature that changes with age 1451 . Low 
frequency 
trends in the quasi-static PPG level and arterial pulsations amplitude have been 
[46] 
attributed to the effects of respiration and vasomotion 
1.5.2 Major Applications of Photoplethysmography 
One of the major applications of PPG is in the area of pulse oximeter [47] which 
measures the oxyhemoglobin saturation in the arterial blood. It relies on the 
knowledge that when two compounds with differing absorption spectra are together in 
a given solution, the ratio of the two concentrations can be determined from the ratio 
of the light absorbed at two different wavelengths. PPG is also used for the studies of 
peripheral vascular compliance [481 and more recently, for monitoring the oxygen 
status of the foetus during labour and delivery 
[49] 
. Others have used PPG to measure 
[50] [511 
physiological variables such as respiratory rates and peripheral arterial pressure 
[52] 
The pulsatile microcirculation was also studied in its relation to hypertension 
Bilateral PPG pulse waves at multi-sites were used to diagnose vascular patients with 
asymmetrical disease [53] . Venous PPG signals 
have been used in a variety of 
functional venous hemodynamics testing situations [54] , with recent advance in 
calibration of these signals [55] spawning increased clinical interest. 
Here, we shall hereby examine the main application of PPG signal, namely, pulse 
oximetry. Pulse oximetry remains the dominant clinical application of PPG but also 
serves to demonstrate the use of arterial pulsations to isolate the absorption due to 
arterial blood, thus, enabling a non-invasive spectral blood analysis. 
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1.6 PULSE OXIMETRY 
Pulse oximetry is arguably the greatest advance in patient monitoring since 
electrocardiography. It enables oxygenation, an important physiological variable that 
is poorly detected in clinical means, to be monitored continuously, simply, and non- 
invasively. This methodology relies on the knowledge that deoxyhemoglobin and 
56] 
oxyhemoglobin absorb light at varying degrees as a function of wavelengthf 
Currently, most commercially available pulse oximeters use two wavelengths of light; 
one in the red band (660nm) and the other in the infrared band (940nm). 
Since at 660nm. deoxyhemoglobin absorbs more light than oxyhemoglobin, and at 
940nm, oxyhemoglobin absorbs more light than its reduced form (Figure 1.11), pulse 
oximetry relates this differential measurement to the arterial oxygen saturation. 
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Figure 1.11 - Absorption spectra 01 oxyhemoglobin and deoxyhemoglobin, 
showing the two most commonly used wavelengths 
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A consideration of the optical spectra highlights that a choice of wavelengths on the 
opposite sides of the Isosbestic point, that is, the wavelength at which the absorption 
of the hemoglobin species are identical (around 800-815nm), will give the greatest 
contrast possible. In living tissues, however, light is also being absorbed by the tissues 
and by the hemoglobin in venous and capillary blood. 
The breakthrough was the realisation that the light absorbed varied with each pulse. In 
addition, if the absorption was measured at one point of the pulse wave and compared 
with the absorption at another point, then the difference between the values was due 
to arterial blood alone; the contribution of other absorbers could thus be eliminated. 
1.6.1 Principle of Operation 
The degree at which oxygen is chemically combined with hemoglobin is referred to as 
thefunctional arterial oxygen saturation or Sa02. It is the ratio of the concentration of 
oxyhemoglobin (Hb02) to the sum of oxyhemoglobin and deoxyhemoglobin (Hb02+ 
Hb) that is present in the arterial blood stream: 
Sa02 :- 
TTLO 
110 2 
Hb + Hbo2 
X100% ...................................................... 1.9 
Sa02 is closely related to ftactional arterial oxygen saturation, which is the ratio of 
oxyhemoglobin to the total hemoglobin of all species including carboxylhemoglobin 
and methemoglobin. Since the amount of oxygen physically dissolved in blood is 
small in comparison with oxygen being chemically combined with hemoglobin, 
functional or fractional arterial oxygen saturation gives a good measure of the 
oxygenated state of hemoglobin in the blood stream. 
In order to distinguish between the two species of haemoglobin, mainly 
oxyhemoglobin and deoxyhemoglobin, two separate wavelengths, A] and A 2, are used 
to illuminate the vascular bed. The transmitted light is then measured. 
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The pulse oximeter first determines the AC component of the absorbance at each 
wavelength and then divides it by the corresponding DC component to obtain a 64pulse 
added" absorbance that is independent of the incident light intensity. The ratio of 
ratios (R) of the pulse added absorbances are related to arterial oxygen saturation 
(Sa02): 
R= 
A C., I DC,,, 
.................................................................. 
1.10 
AC 
A2 
IDC A2 
In practice, the two light sources must be multiplexed so that each source provides 
illumination for a discrete time period during which the intensity may be measured. 
1.6.2 The Beer-Lambert Law 
The Beer-Lambert law states that the transmission of light through a turbid medium is 
a logarithmic function of the density or concentration of the absorbing molecules in 
the solution. The intensity of the transmitted light is also a function of the length of 
the path the light travels through the solution and the absorbance constant for a given 
absorbing particle at a given wavelength. This law may be written as the equation: 
I(A) = Io (A) exp(-, uff (A)r) .................................................... 1.11 
Where r is the path length, pfj(A) is the effective absorbance. The constant 10 can be 
interpreted here as the source intensity, and has wavelength dependency to account 
for the discrete narrow-bandwidth sources used in pulse oximetry. The pulse oximeter 
also used the Beer-Lambert law, but with important empirical corrections. For the 
Beer-Lambert law to be valid, both the solvent and the cuvette must be transparent. 
The length of the light path must be known exactly and no other absorbers can be 
present in the solution. However, it has been shown that this approximation to the 
complex optical interactions that occur in living tissue can give a good first order 
[57] 
solution 
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The primary assumption of the Beer-Lambert formulation is that the optical path 
through tissue may be separated into a static component and a small dynamic 
component that depends solely on the wavelength-dependent absorbance of the 
pulsating arterial blood. 
This can be expressed by decomposition of the macroscopic optical density: 
p, ff (A)r ': - '- Pblood(A)d(t) + p,,,,,,, (A)l ........................................... 1.12 
where Pblood(A) and p, i,,,,, (A) are effective absorbance for the blood and tissue 
respectively, d(t) is the dynamic path length through the pulsating blood (assumed to 
be identical for all wavelengths) and I is the constant path length through all other 
anatomical components. 
The dynamic component is further decomposed by virtue of the absorbance 
differences between oxyhemoglobin and deoxyhemoglobin at the illuminating 
wavelength: 
Pblood ('ý) = SPHbO2 (A) + (1 - 
S), UHb (A) 
........................................ 1.13 
S is the proportion of hemoglobin that is oxygenated (or in other words, the desired 
arterial oxygen saturation, Sa02). This allows us to write the received intensity at a 
particular wavelength, A, in terms of the oxygen saturation, the constant effective 
absorbances and the path lengths: 
I(t, A) = I, (A) exp- 
ý(SPM02 (A) + (1 - S)PHb (/')P(t) + U, i,,,,, 
(A)' ý 
....... 1.14 
It is therefore possible to generate instances of the above equations at different 
wavelengths and solve these to obtain a value for the oxygen saturation. The 
following example solution is conceptually based on one of the most predominant 
used algorithms and serves to introduce both common methodology and terminology. 
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1-6.2a The Logarithmic Solution 
In order to obtain a linear equation in S, the natural logarithm of the intensity can be 
used to isolate the multiplicative source constant, Io(ý), 
In I(t, A) = In I, (A) - 
(SpHb02 
(A) + (1 - S)PHb (A)P(t) - Pti,,,,, (A)' ......... 1.15 
Since both the source constant and the tissue absorbance are time invariant, we can 
eliminate them by considering the time derivation of the equation, 
d [In I (t, A)] 
= -(SpHbo2 
("Z) + (I _ S)pHb(, Z))d[d(t)] .......... 1.16 dt dt 
The derivative of d(t) is an unknown dynamic but according to this standard model, is 
not wavelength dependent. Thus, the two instances of the equation above may be 
generated at two wavelengths and a ratio constructed to eliminate any dependence on 
d(t): 
d[In I(t, /ý)] 
dt 
SpHb02 + S)IUHb Pblood 
R ............. 1.17 d[InI(t,. A2)] - SpHb02 + S) PHb Pblood ('12 
dt 
The ratio R, determined from the measured intensities at the two wavelengths, is the 
ratio of ratios and is defined as the ratio of the absorbance of blood at the two 
illuminating wavelengths. This unknown oxygen saturation, S, may be determined 
from the measured R and knowledge of the four effective absorbances: 
s 
RpHb (A2)-pHjlý) 
)= 
SaO2 
R 
ýpHb 
'UHbo2 
(/ý ))- (pHb (/ý )- PHb02 
(/ý ) 100% 
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1.6.3 Calibration 
The simple model of the relationship between S and R presented in the last section is 
only approximately true. For example, the two wavelengths do not necessarily have 
the exact same path length changes, and second-order scattering effects have been 
ignored. In practice, the four effective absorbances will not be derived theoretically, 
but will be based upon an empirical calibration through the employment of induced 
hypoxia experiments [58] -A typical empirical calibration versus the Beer-Lambert 
model is illustrated in Figure 1.12. The final empirical calibration will ultimately 
depend on the details of an individual sensor design, but these variations can be 
determined for each sensor and included in unique calibration parameters. 
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Figure 1.12 - Empirical Calibration versus Beer-Lambert model 
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1.6.4 Limitations of Present Pulse Oximeters; 
Pulse oximeters suffer the same limitation as any two-wavelength system for 
measuring oxygen saturation in the blood. Adult hemoglobin typically contains four 
different species; oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and 
methemoglobin. As most commercially available pulse oximeters use only two 
wavelengths, only two Hb species can be measured. Carboxyhemoglobin (COHb) 
looks like Hb02 at 660nm, whereas COHb is relatively transparent at 940nm. In the 
presence of large amounts of COHb (such as in the case of carbon monoxide 
poisoning), the pulse oximeter Sa02 saturation readings could be indicated 
incorrectly [59] 
. Motion artefact occurs when the oximeter sensor is subjected to 
excessive motion and at present, the problem is tackled using proprietary signal 
processing techniques 
[60,61] 
, mechanical designs of a new finger probe 
1621 
and more 
[63] 
recently, through signal equalisation with an extra control source 
Poor blood perfusion is also commonly encountered in clinical settings when using 
pulse oximetry. Oximeters depend on an identifiable arterial pulse to operate properly. 
Conditions such as hypotension, hypothermia and hypovolemia can act to block 
sensor readings for oxygenation [64] . Other factors that affect pulse oximetry accuracy 
include ambient light artefacts experienced in the operating theatreS[651 and nail 
polish [66] . Studies have shown that changes 
in the volume fraction of blood contained 
in the tissue can affect the slope and offset of the oximeter calibration curve. 
However, within clinical situations during which a patient's arterial oxygen saturation 
is greater than 70%, errors introduced by blood-volume fluctuations are not likely to 
exceed one or two percent if the pulse oximeter is calibrated for a blood volume 
fraction in the normal physiological range 
[67] 
. 
If the venous blood volume changes within the tissues are comparable or less than 
that of the pulsatile component, it would not affect the accuracy of the pulse oximeter 
drastically. However, in cases whereby the change of blood volume is due to some 
physiological factors which leads to significant redistribution of venous blood in the 
tissues (such as during exercise), pulse oximetry readings will be affected. 
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1.7 SUMMARY 
The importance of oxygen to the human body has been presented in this chapter. Due 
to the small reserve of oxygen within the human body, we need to constantly 
replenish its supply through respiration. It is therefore also even more vital, that we 
have a minute-to-minute monitoring of the oxygen saturation in the blood during 
intensive care. The role of the arterial and venous blood in oxygen transport has been 
outlined with an illustration of the human cardiovascular system. 
Venous oximetry is important within a clinical environment in assessing a patient's 
oxygenation. The extant techniques used in venous oximetry are mainly through using 
fibre-optic catheters in the pulmonary artery and Near Infra Red Spectroscopy 
(NIRS). The present non-invasive technique (NIRS) is not suitable for replacing the 
invasive method due to its calibration problems. 
The current invasive technique has limited the use of venous oximetry in clinical 
environments. Therefore a new non-invasive method is needed to supplant the current 
technology and help venous oximetry with achieving its best clinical impact. 
The last portion of this chapter was devoted to introducing photoplethysmography 
(PPG) and its main application, pulse oximetry. An in-depth look at the PPG 
waveform and the theory of pulse oximetry based on the Beer-Lambert law were 
presented. Although there are quite a few factors which could affect the accuracy of 
pulse oximetry, generally it is accurate and is considered the greatest advance in 
[68] 
patient monitoring after electrocardiography 
The chapter attempts to lay the foundation for understanding the new proposed 
method of venous oximetry, which is closely related to photoplethysmography and 
pulse oximetry. The chapter has also sufficiently shown that venous oximetry is an 
important part of clinical care and the invention of a new non-invasive venous 
oximetry technique that could be used extensively within a clinical environment 
would bring about a significantly positive impact in clinical care. Finding a solution 
for a non-invasive venous oxygen monitoring technique is indeed worthwhile and 
warrants extensive research. 
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MODELLING 
The new method of non-invasive venous oximetry involves introducing a 
pulsatile signal into the venous system; the aim of which is to transform the 
quasi-static venous system into a dynamic, pulsating system. In this way, 
venous oxygen saturation could be determined in the same way as arterial 
oxygen saturation in pulse oximetry. The induced artificial pulsation is made 
to be comparable in amplitude to the PPG signal. At an early stage in the 
research, a mathematical model was developed which is based on a heuristic 
model of the PPG signal in order to explore the nature of the artificial pulse, 
its effect on the underlying PPG signal and any other physiological effects it 
might produce. It is hoped that any additional artefacts introduced into the 
system could also be identified here. Another model will also be developed 
which is an extension of the modified Beer-Lambert law. This model is 
commonly used as a first order approximation for pulse oximetry. It will be 
used to demonstrate how the additional artificial pulse can be used to relate 
to venous oxygen saturation. 
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2.1 ARTIFICIAL VENOUS PULSATILE SIGNAL 
An artificial pulsatile signal is externally generated so as to cause the venous blood to 
pulsate in a given frequency. The aim of inducing a mild perturbation in the venous 
system is to cause a pulsation that is comparable to the PPG signal present in the 
arterial system, such that the same principle of measuring arterial oxygen saturation 
can be similarly applied to the venous system. The actual means of implementing the 
pulsation shall be examined in later chapters. The effect of introducing a pulsatile 
signal into the venous system can be viewed as introducing an artefact into the PPG 
signal, thus a heuristic PPG model [691 previously developed to examine the effect of 
motion artefacts on PPG can be used in this case. When the idea of introducing an 
artificial pulse into the venous system was first conceived, the hypothesis was that the 
artificial venous pulsatile signal will have an additive effect on the underlying PPG 
signal, and that the two signals can be separated spectrally. The heuristic model is an 
intermediate step in proving the hypothesis and it is hoped that the model will also 
help us to anticipate the behaviour of the artificial pulse and its interaction with both 
the venous and arterial systems. 
2.1.1 The Heuristic PPG Model 
The most common assumption of PPG studies is that changes in measured light 
intensity transmitted through or reflected from a vascular bed are induced by changes 
in blood volume. Due to the fairly uniform distribution of blood volume in 
vasculature, the heuristic PPG model describes the effect of those blood volume 
changes as modulations in the homogeneous and macroscopic optical properties of 
tissue. Certain aspects of the physical behaviour of the PPG can be described as being 
independent from the chosen model. The heuristic PPG model was formulated 
[701 
according to this behaviour 
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2.1.2 Definition of the model 
Light is transmitted through or reflected from the anatomy of the patient, resulting in 
a measured intensity that depends upon the wavelength and intensity of the source, as 
well as any optical interactions with the subject. The primary assumption of this 
model is that the received intensity can be separated into components originating from 
the different optical paths, therefore identifying and specifying distinct optical effects. 
We will examine the case when a number of light sources can be used in conjunction 
with a single receiver to generate one or more PPG signals. The received light 
intensity as a function of time, t, and wavelength, A, is modelled by, 
n 
Ij (t)[aj (t) + pj (t, A) + yj (t, A)] ................................... 2.1 
j=l 
wherej labels the light source of intensity Ij and aj, fij, yj are coupling coefficients that 
depend on the geometric, temporal and spectral properties of the source / receiver 
positioning, arterfact, tissue dynamics and the optical properties of both skin, blood 
and tissue. The coefficient aj is interpreted as direct coupling between source and 
receiver and those labelled fij, yj correspond to light coupled via non-pulsatile and 
pulsatile tissue respectively. The coefficient fij encompasses the coupling of light from 
any anatomical components that is not associated with dynamic arterial blood volume. 
In many instruments, the light sources emit fixed power levels. Here, however, they 
will be permitted to vary for the sake of generality. It is assumed that the effects of 
ambient light have been successfully eliminated by an electronic multiplexing 
technique. By attributing the dynamic portion of the pulsatile signal tissue coupling 
coefficient, yj to an underlying pulsatile signal pj(t), 
yj (t, A) = 7j (11)pj (t) .............................................................. 
2.2 
it can be assumed that the pulsatile signal represents a 
dynamic change in arterial 
blood volume and / or macroscopic optical properties of the tissue, which can 
ultimately be related back to a 
dynamic change in optical path length. 
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It is this optical path length change that causes the dynamic modulation of the 
coupling coefficient expressed in equation 2.2, and therefore the observed intensity 
fluctuations in equation 2.1. 
2.1.3 Applicability 
The model developed is underpinned by two fundamental assumptions: 
1. The received intensity may be separated into components that can be 
attributed to the passage of light through various optical paths, with the optical 
coupling efficiency being free to change between distinct paths. There is no 
restriction on the physical model, which may vary between paths. 
2. The arterial blood pulsations may be modelled as a change in optical path 
length that ultimately modulates the coupling of light from pulsatile tissue. 
Although these assumptions are conceptually similar to those employed in 
conventional interpretations of PPG signals by technologies such as pulse oximetry, 
the generality is much improved by the heuristic nature of the model. Within the 
context of these assumptions, the heuristic model may be used to describe both 
venous and arterial PPG signals. The model does not dictate physical interpretation of 
the signal, nor does it attempt to explain the complex optical interactions. 
2.1.4 Interpretation of the Model 
The model of equation 2.1 is simply a convenient method of describing the observed 
intensity and its fluctuations. The coupling coefficients identify different optical paths 
with different optical coupling efficiencies, and therefore, separate the received 
intensity into optical-path dependent components. In order to attribute physical 
significance to these coefficients, it is necessary to 
invoke an analytic optical model 
that relates the observation of intensity fluctuations to the origin of the optical paths. 
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The heuristic model has been interpreted previously by two physical models; the 
Beer-Lambert model and diffusion theory modd701 . Both analyses have shown that 
the coefficients can be attributed to physical significance. 
2.2 ARTIFICIAL PULSATILE SIGNAL HEURISTIC MODEL 
The introduction of an artificial pulsatile signal into the venous system can be 
modelled by modifying the heuristic model. The artificial pulsatile signal can be 
modelled as a sinusoidal signal, 
v. sin(ü), t + 0. ) ........................................................... 2.3 
where vO is the coefficient of the modelg com is the modulating frequency and 0,, is 
the phase angle that might be present in the modulating signal. The modulating signal 
can be generated externally through mechanical and electronic means. 
The PPG heuristic model separates the received intensity into different optical-path 
dependent components, with the coupling coefficients each identifying a separate 
optical path. With the introduction of an artificial pulse, the following further 
assumptions are made: 
ai 
Due to the design of the finger probe, there is no direct coupling between the source 
and the receiver. The coupling coefficient, Pj which accounts for light coupled through 
non-pulsatile anatomical components and within the context of the artificial venous 
pulsation, can be separated into light coupled through tissue alone and 
light coupled 
through both tissue and pulsatile venous blood. The expanded coefficients can be 
written as: 
fij'(A) - coupling through static tissue only 
and 
T+ -vn (t)]- coupling through static tissue andpulsatile venous 
blood only 
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Similarly, the coupling coefficient, yj can also be separated into two different optical 
paths and can be written as: 
yj T+'4 (A)pj(t) - coupling through static tissue andpulsatile arterial blood only 
and 
Yj 
T+A +V (-Z)pj(t)[1-vm(t)] - coupling through static tissue, pulsatile arterial blood 
andpulsatile venous blood 
By combining all these terms, the extended heuristic model can be written as: 
n gT (A) + 
T+V (A)[I 
- V. 
(t)] . 
............ yJ. 18i 
*2.4 T+A 
j j(t)+; VT+A+V(A)pj(t)[I_Vm(t)] j=l pi 
The model separates the received intensity into all the possible optical paths and 
accounts for the DC and AC PPG signals, as well as the artificial venous pulsatile 
signal. Although the model cannot attribute physical significance to each term, it 
shows the different components that are present resulting from any interactions 
between the artificial venous pulsatile signal and the underlying PPG signal. 
Expanding the terms in the equation 2.4 above gives rise to: 
n 
gT (A)+ gT+V (A)_ 
)6 ý+V (A)V . ...... m 
j=l ;V 
T+A (A)pj (t) + 
'y 
T+A+V (A)pj (t) T+A+V (, Z)pj (t)Vm (t) 
iii 
T T+V 
The first two terms in the expanded model in equation 2.5,8, ' (A) are 
independent of the two pulsatile signals and collectively constitute the DC PPG signal 
as in the original PPG heuristic signal. The next term,, 
8 T+V (A)v,, (t) is the artificial i 
pulsatile signal and its relation with the remaining terms are additive. 
Therefore, it is 
possible for it to be extracted spectrally, providing the modulating 
frequency of the 
artificial pulse is distinctively different from the 
PPG signal frequency. Of course this 
is only an assumption whose validity is only 
demonstrated in later practical 
investigations. 
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'Y 'Y 
T+A (A)Pj (t)" T+A+V The next two terms in the expanded model, ,ii 
(A)pj (t) constitute 
the PPG signal since they only consist of the pulsatile coupling coefficient and the 
T+A+V underlying pulsatile signal, pj(t). The last term of the model, yj (A)Pj (OV, W 
will be referred to as the multiplicative term and is the result of coupling between the 
two pulsatile signals. 
The multiplicative term, which will be explored in more detail in later chapters, is the 
single most important parameter in optimising the design of artificial-pulse based 
venous oximetry. The magnitude of the multiplicative terrn is the measure of the 
degree at which the arterial system is being disturbed. Such a disturbance can affect 
the amount of arterial blood being delivered to the tissue and thus, render any 
measurements of venous oxygen saturation inaccurate. 
It would be advantageous to know at what frequencies the multiplicative term would 
appear. In this way it could be easily identified within a frequency spectrum. This 
would help in the design of digital filters when separating the two pulsatile signals 
spectrally. If we model the pulsatile signal, pj(t) as: 
00 
pj 1: p,, sin(ncoRt + 
OnHR) 
................................................... 
2.6 
n=l 
where p,, is the coefficient, coHRis the PPG fundamental frequency, n represents the 
harmonics (n=l is the fundamental frequency), and OnHR is the phase involved. This is 
just a first-order representation of the PPG signal but nevertheless, it is an adequate 
representation in our present analysis as a PPG-like waveform can be constructed 
using two sinusoidal waves as illustrated in Figure 2.1. 
HAPTER 2 39 
MODELLING 
Figure 2.1 -A PPG-like waveform constructed by combining two sinusoidal 
waves, y=2 sin(x) + 0.75 sin(2x - 0.5) 
The multiplicative term due to the fundamental PPG signal can be written as: 
pj (t)v. (t) = pl sin(a)HRt + 
01"R)vo 
sin(co, + oj ................................ 2.7 
By invoking the following trigonometric identity: 
2 sin A sin B= cos(A - B) - cos(A + B) ...................................... 2.8 
The multiplicative term in 2.7 can be expanded as: 
1 cos(N 
mt - 
OJHR t+ om _ 
01 HR ).......... 
..................... 2.9 pi (t)vm (t) =2 P1V0 
COS«Omt + (OHRt + om + 0, 
HR ) 
By expanding equation 2.7 through invoking the trigonometric identity (equation 2.8), 
it can be seen that the multiplicative term will appear at frequencies on either side of 
the artificial pulse modulating frequency as follows; at the difference and the sum of 
the PPG fundamental frequency, coHRt and the artificial venous pulse modulating 
frequency, Coj - 
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The magnitude of the multiplicative term depends on both the magnitudes of the AC 
PPG signal and the artificial pulse modulation depth. Since the AC PPG magnitude is 
small (1-5%) as compared to the total absorption, we can safely assume that the 
degree of coupling can be minimised if the artificial venous pulse modulation depth is 
also small. 
The heuristic model of the artificial pulse-based venous oximetry technique assumes 
that the effects of introducing an artificial pulse to the venous system on the 
underlying PPG signal are both additive and multiplicative. The multiplicative effect 
can be minimised and made insignificant through optimising the different parameters 
in the actual design of the instrument. The mainly additive nature of the artificial 
pulse is desirable as it would imply that the artificial pulsation would not affect the 
arterial system if the modulation depth remains small, and that it can be separated 
from the PPG signal through filtering techniques such as using a narrow bandpass 
filter centred at the modulation frequency. 
2.3 BEER-LAMBERT MODEL FOR VENOUS OXIMETRY 
The heuristic model of the artificial pulse based venous oximetry technique developed 
in the last section is a convenient way of describing the observed intensity and its 
fluctuations. The terins within the heuristic model account for all the different 
possible optical paths. Thus, the model separates the received intensity into optical- 
path length dependent components. In order to lend any physical significance to the 
different terms, it is necessary to recourse to a specific physical model that will relate 
the observed intensity fluctuations to the origin of the pulsations. We will now 
consider the Beer-Lambert model to see how the introduction of an artificial pulse 
could be used to derive the oxygen saturation in the venous blood. We will also see 
how this physical model can be used as an interpretation of the heuristic model. 
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2.3.1 Generalized Arterial and Venous Pulse Oximetry 
The Beer-Lambert law, which couples physical path length and effective absorbance 
into a single definition of optical density, is commonly used in arterial pulse oximetry 
to assign physical significance to changes in the optical path length. Extending the 
lowest order conventional description of arterial pulse oximetry can make a zeroth 
order theoretical description of the artificial pulse based venous oximetry. According 
to this model, we can write the received intensity due to a particular illuminating 
wavelength, /I in terms of the proportion of arterial hemoglobin that is chemically 
combined with oxygen, S. Recalling equation 1.14 developed in chapter 1, 
I (t, A) = I,, (A) exp- 
I(Su,,,, (A) + (I - S) pHb (A)) d (t) + (A)lý ......... 2.10 
where PHbO2 (A), ub(A) are the effective absorbance of oxygenated and de- 
oxygenated hemoglobin respectively, d(t) is a function of the dynamic physical path 
length through arterial blood, and p,,,,, i, (A)l is the optical density of the non-pulsatile 
tissue and other anatomical components. 
By distinguishing optical paths through venous blood, d, (t) and arterial blood, d, (t) 
we may generalize equation 2.10 to 
i(t, A)= I, (/I)exp- lu, d,, (t)+ p, d, (t)+ p,.,, (A)Ij ......................... 2.11 
by making the following substitutions: 
GO 
+ 
(1 
- 
Sa )PHb 
P, 
[Sa 
PHbO2 
.. 2.12 1) + SV )PHh ISVPHbO2 (/ 
We will now explore small changes in the received intensity resulting from small 
changes in the optical paths (resulting 
from the presence of low amplitude venous and 
arterial modulations) and consider the resultant changes 
(AQ normalized by the 
quasi-static (DC) intensity, namely: 
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A. I (t, A) 
I(t, A) = PaAda(t)-p, 
Ad,, (t) .............................................. 2.13 
The quantities expressed in equation 2.13 can be separated by electronic (or other 
signal processing methods) since the induced venous modulations are of known 
origin. One method of separation would be to induce a frequency modulation of the 
venous system in a band that is distinct from the arterial pulsations. Once the isolation 
of the arterial and venous dynamics is achieved, the process of calibration can be 
applied. Inversion of the classical Beer-Lambert model of pulse oximetry is usually 
achieved by generating two instances of equation 2.13 at two different wavelengths. 
These equations are then solved for the quantity, ratio of ratios, R, which is defined 
as the ratio of the absorbance of the illuminated blood at the two wavelengths used. 
Assuming each ten-n in equation 2.13 has been isolated, we may form two "ratio of 
ratios": 
Ra 
[ At, 
'ý2 W(tý'O 
L At, A, )AI(t9 A2 )I 
a 
Rv 
At, '2 )Ai(t, Al)]v 
AtýAJAI(t9 A2 ) 
PIR) P, (A2 ) 
**'*******'***" ...... ****'*"*'*"* ........ 
2.14 
lul 
(A, ) 
P, 
(A2 ) 
Knowledge of the extinction coefficients of oxygenated and deoxygenated 
hemoglobin at the two wavelengths can then be used to estimate S, S, from the 
calculated R using the formulae as follows: 
Sa = 
Ra 
sv = Rv 
RaPHb G'12 )- 
JUHb 
Gýl ) 
Hb 
Gý2 
J"HbO2 
Gý2)1- IUHb ('*I' ) 
-'"Hbo2 
("I' 
...................... 
2.15 
RvPHb Gý2 )- 
J"Hb 
("I ) 
Hb 
Gý2 PHbO2 Gý2 )l - 
IPHb ("1' PHb02 (111 
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2.3.2 Beer-Lambert Model Interpretation 
In order to lend any physical significance to the heuristic model, we will now attempt 
to interpret the heuristic model using the Beer-Lambert model. The Beer-Lambert 
model is used here to describe the case of transmission through tissue, as is common 
in pulse oximetry. With the introduction of an artificial pulse, the resulting measured 
intensity can be expressed as 1oT(z,, z, u); where 10 is the incident intensity and 
is the transmittance of the tissue which is dependent on the two optical path 
lengths through arterial blood (z, ) and venous blood (z, ), and the effective absorbance 
(u). The transmittance is expressed by reference to the modified Beer-Lambert law 
(equation 2.11): 
T(Za 
ý Z,, 
P)= expl-(Z, + ZV)Pl ................................................ 2.16 
2.3.2a Separation of Signal Components 
The transmitted intensity will consist of a static component and two dynamic 
components that are primarily due to the arterial pulsation and the artificial venous 
pulsations. Therefore in this interpretation, the dynamics in the homogeneous and 
macroscopic optical properties of the tissue can be related back to the components in 
our heuristic model. We can write the total transmittance (through both pulsatile and 
non-pulsatile components), in terins of the previously defined coupling coefficients: 
fiT +, gT+V [I _ Vm 
(t)] +,, T+Ap(t) +,, 
T+A+Vp(t)[I 
_ Vm 
(t)] 
T(z, + Az, (t) + zv + Azv (t) +p+ Ap(t)) ............................ 
2.17 
Where we have assumed that there is no direct coupling between source and receiver, 
we have attributed some physical significance to the pulsatile signal, p(t) and v, '(t). 
This is achieved by modeling its effect as a dynamic change in optical path length, 
due to either a dynamic change in the two physical path lengths or in the macroscopic 
effective absorbance of the tissue. 
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Because Az,, (t), Az, (t) and Au(t) are small by comparison to their static counterparts, 
we may linearise equation 2.17 with respect to these small changes using a first order 
Taylor expansion, 
(Z 
a+ Az a 
(t)" Zv +AZv (0ý P+ AP(t)) - 
T(Za 
9 
Zv p) + AZa 
U(za 
5 Z, I P) + Az 
laZa v 
dDT(Za 31 Zv , IU) + 2T(z a9 
ZO P) 
............. 2.18 
(3z v aju 
which enables us to write: 
T T+V T+A T+A+V 
'8 +, 
8 [1 - V. (01 +; v p(t) +7p (t) 11 - V. (01 -].......................... 2.19 
exp [-(z,, + z, )p] [I - (Az, (t) + Azv (t)) p- Ap(t)(z, + z, ) 
Since the heuristic model coefficients can be separated into static and dynamic 
portions, we can rewrite equation 2.19 as a ratio of the dynamic to the static 
components as follows: 
_, 
gT+VVm (t) +,, T+Ap(t) +; VT+A+Vp(t) _; VT+A+Vp(t)vm 
(t) 
, 
8T +)t3T+V 
............................. 2.20 
- (Az,, (t) + Az, (t)) p- Ap(t)(z, + z, ) 
In equation 2.20, it can be assumed that the multiplicative term, p(t)v,, (t) is small and 
can therefore be omitted in the equation. Furthermore, the modified Beer-Lambert 
model for venous pulse oximetry developed in the last section, assumed that the 
observed pulsations are due to changes in the physical path length through blood only. 
This implies that the total transmittance may be written as: 
T(Utissue, r, iUblood 9 Za + 'ýýZa (t), Z, + Az, (t» =: 
.......... 2.21 
exp- (jutissuer+ #Ublood 
(Za + AZa (t» + jUblood 
(Zv + 'ýýZv 
(t») 
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In this case equation 2.20 reduces to 
T+V 
vm (t) +; VT+AP(t) + YT+A+V p(t) 
PT + 8T+V 
= -(Az, (t) + Az, (O)Pblood .................... 2.22 
Since the two pulsatile signals are additive and the effective absorbance of blood can 
be separated into that of the arterial and venous blood, equation 2.22 could be 
rewritten as two separate equations; one each for the case of the artificial venous 
pulsatile signal and the PPG signal, 
- 18 
T+V 
v v,, (t) = -Az, (t), uv ................................................... 2.23 j6T +, BT+ 
and 
; VT+A + YT+A+V 
p(t) = -Az,, (t)p . ............................................... 
2.24 
)oT +, gT+V 
When using the physical model and the assumptions employed for deriving both 
venous and arterial oxygen saturations in section 2.3.1, equation 2.23 and 2.24 tell us 
that the ratio of coupling coefficients is now equal to the effective absorbance of the 
venous and arterial blood only. The ratio of ratios used to calculate oxygen saturation 
is defined as the ratio of the absorbance of the illuminated blood at two wavelengths. 
It can therefore be seen that the ratio of the two instances of equations 2.23 and 2.24, 
can be used to rewrite the oxygen saturation in terms of our heuristic coupling 
coefficients. 
This useful method of interpreting the heuristic model through the physical model of 
Beer-Lambert law illustrates how physical significance can be attributed to the 
components of our artificial pulse based venous oximetry heuristic model in a specific 
context. Observations of the behavior of these heuristic components may then be 
extrapolated back to their physical counterparts, thus providing insights that would 
be 
otherwise difficult to obtain. 
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The use of Beer-Lambert law has served to enable us to place the model within the 
context of standard oxygen saturation derivation as in pulse oximetry whilst 
maintaining a high degree of simplicity. 
The physical significance of the heuristic model has been illustrated through this 
analysis of interpreting the heuristic model through the Beer-Lambert law. Other 
interpretations are possible and in later chapters, the heuristic model will be 
interpreted through experimental results. The appearance of the multiplicative terms 
on both sides of the modulation frequency and the additive nature of the artificial 
pulse (as predicted by the heuristic model), should be evident in the experimental 
results. In the simplistic Beer-Lambert model, we have related the parameters of our 
choice of physical model to the parameters of the heuristic model. This enables us to 
physically interpret the observed intensity dynamics in terms of the model for the 
origin of the pulsations and characteristic of the tissue. 
2.4 SUMMARY 
The chapter started with an introduction to the heuristic model of PPG. The model 
was then modified and expanded to include the introduction of an artificial venous 
pulsatile signal. The heuristic model's primary assumption is that the received 
intensity can be separated into components originating from different optical paths. 
The new venous oximetry heuristic model helped to identify the different effects of 
introducing a pulsatile signal into the venous system. The effects of the artificial pulse 
are mainly additive with respect to the underlying PPG signal. The coupling between 
the arterial system and the artificial pulse is manifested as a multiplicative terin and of 
which the magnitude will remain insignificant, providing that the modulation depth is 
small. The heuristic model also enables complex behavior to be expressed in a general 
manner. The model has been interpreted in terms of the Beer-Lambert law, attributing 
both the pulsatile components, arterial pulsations and the artificial venous pulsation 
along with the static parameters of the heuristic model to physical significance. 
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The Beer-Lambert law has also been modified such that venous oxygen saturation can 
be derived from it. The derivation does not differ much from the classical way of 
deriving arterial oxygen saturation. The primary assumption made in using the Beer- 
Lambert model is that the multiplicative term is small and can be made insignificant 
through careful design of the instrument and by minimizing the modulation depth of 
the artificial pulse. 
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3, IMPLEMENTATION 
The first two chapters of this thesis laid out the methodology in achieving a 
non-invasive venous oximetry method that is suitable to be used in a clinical 
envirom-nent. In this chapter, we shall look at how the new technique's 
mechanical and electronic designs can be implemented. The hardware 
involved in this new venous oximetry technique includes a standard PPG 
system that records PPG waveforms through a transmission mode finger 
probe, a digit pressure cuff, a pinch valve for modulating the inflation and 
deflation of the digit cuff, and an air pump that serves as an air source for the 
digit cuff. The implementation of the electronics, the hardware and the control 
software for inducing a pulsatile signal in the venous system will be described 
and outlined in this chapter. 
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3.1 NEW VENOUS OXIMETRY METHODOLOGY 
The proposed new method of venous oximetry involves inducing a localised artificial 
venous pulsation so as to transform the otherwise quasi-static venous system into a 
pulsatile system. This artificial venous pulsatile signal's magnitude can be made 
comparable to the PPG. In this way, peripheral venous oxygen saturation can be 
determined in the same manner as arterial oxygen saturation in pulse oximetry. The 
figure below shows the block diagram of the new venous oximetry method. 
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Figure 3.1 - Block diagram of the new venous oximetry method 
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First of all, a means of inducing venous blood volume changes was applied to the 
vascular tissue under test. The localised peripheral venous blood volume was 
modulated at a given frequency so as to facilitate the recovery of the artificial 
pulsatile signal during post-processing. The artificial venous pulsation along with the 
PPG signal were digitized and recorded via an optical probe. The two digitised signals 
were separated spectrally through signal processing. After the signals were separated, 
the artificial pulse was analysed to derive parameters relating to venous oxygen 
saturation. 
3.1.1 Methods in Generating the Pulsatile Signal 
There are various means of generating the artificial pulse. Since we are using a 
standard transmission mode finger probe to record the PPG signal, it would prove 
useful to generate a localised artificial venous pulsation near the index finger. In this 
way, the signal could be recorded via the same finger probe. The small artificial 
venous pulsatile signal could be generated externally at a site which is proximal or 
distal from the area through which light is transmitted. Should this distance become 
too close, the physical perturbation in the area of light transmission can cause changes 
in the light coupling to the medium under test. If this were to materialise, there will be 
variations in attenuation which are not due to changes in fluid volume in the area of 
light transmission. These other variations comprise additional noise that should be 
removed for accurate measurement. 
One way to generate the artificial pulse is to use a jet of air and direct it at a position 
distal or proximal to the measurement site. Modulation of the venous blood volume 
can be achieved by directing jets of air onto the tissue under test at a given frequency. 
This method is feasible but will not be easy to adopt since it is difficult to mount the 
device onto the hand. The method that was finally adopted is to use a digit pressure 
cuff to generate the artificial venous pulsatile signal (Figure 3.2). 
CHAPTER 3 51 
IMPLEMENTATION 
Transmission mode 
Finger probe 
Digit cufff 
Digit cuff is mounted at 
the base (proximal phalanx) 
of the index finger 
Figure 3.2 -A digit cuff is used to generate the artificial pulse 
The pressure cuff was wrapped at the base (proximal phalanx) of the index finger and 
a normal PPG finger probe is also mounted onto the tip of the same finger. A 
continuous inflation and deflation of the digit cuff will cause a mild perturbation in 
the peripheral venous system, causing an artificial venous pulsation which will be 
recorded along with the PPG signal via the finger probe. 
3.1. la Digit Pressure Cuff for Generating Artificial Pulse 
A small digit pressure cuff measuring 9cm by 1.9cm was used to generate the 
artificial pulse. Due to the small size of the digit cuff, the amount of air needed to 
inflate it in order to induce a mild perturbation to the underlying tissues is small. 
Similarly, the digit cuff can be deflated in a relative short time if required, due to the 
same reason. 
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The desired frequency of modulation was achieved by controlling the rate of inflation 
and deflation of the digit cuff. The frequency of modulation is important as it allows 
the generated artificial venous pulsatile signal to be extracted using filtering 
techniques. 
The depth of modulation depends on the pressure of the air source used to inflate the 
digit cuff. In the later chapters we will examine the various suitable pairs of 
modulation frequencies and modulation depths. 
The digit cuff was wrapped at the base (proximal phalanx) of the index finger, away 
from the area of light transmission. This distal position ensured that additional noise 
sources would not be coupled into the artificial pulse during the recording of the PPG 
signal and the artificial venous pulse. 
3.1. lb Air Source for the Digit Cuff 
The air source for the digit cuff must be capable of inflating the cuff within a relative 
short period of time so as to maintain a relatively high modulation frequency (4 -7 
Hz). The air pressure required was in the range of 60 to 160 mm Hg. This range will 
enable us to investigate the effect of the different modulation depths on the localised 
venous system under test. Moreover, the air pump should be relatively simple to 
control through electronic means. A micro-pressure diaphragm air pump was used for 
inflating the digit cuff, which was able to maintain an air flow of 6.1 LPM (litres per 
minute) and a maximum pressure of 260 mm Hg. The air pressure of the micro air 
pump can be controlled by varying the voltage applied across the DC motor which 
drives the diaphragm. Due to the fact that it is a motorised air pump, the noise 
generated can be quite substantial and might not be suitable for a clinical 
environment. In order to minimize the noise generated, the micro air pump was first 
encased in an acoustic absorbing material and then the whole artificial pulse generator 
was put into a metal enclosure. In this way, the noise generated can be minimised to 
an acceptable level. 
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The control of the micro air pump was interfaced to the computer through a 
Programmable Logic Device (PLD) card via the computer's parallel port. The 
electronic circuitry for controlling the micro air pump consists of two major parts; the 
Digital to Analogue (DAC) conversion circuitry and the driving circuitry for the air 
pump. 
The block diagram of the air pump controller is illustrated in Figure 3.3. In order to 
set the air pump to a desired air pressure, a control word was sent via the computer in 
the range of 0 to 256 to the micro air pump via the PLD interface (0 being the 
minimum air pressure and 256 the maximum air pressure). The control word was 
converted into its corresponding current source through an 8-bit DAC and was then 
used to drive the air pump. 
Parallel 
Port Digital-to- 
Computer link PLD card Analogue 
0' interface conversion 
circuitry 
Micro DC motor 
air pump driving 
circuitry 
Figure 3.3 - Block diagram of micro air pump control circuitry 
The circuit diagram for the micro air pump control circuitry is included in the 
appendix. Although there might not be a linear relationship between the air pressure 
produced by the air pump and the voltage applied across its DC motor, the air 
pressure produced at a given voltage can be measured by a pressure sensor. Therefore 
the desired air pressure can be adjusted according to the pressure sensor reading. 
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The micro air pump will provide a constant air source to inflate the digit cuff, with the 
actual modulation of the digit cuff being obtained by using a pinch valve. We shall 
now look at how the modulation of the digit cuff can be achieved using a pinch valve. 
3.1.1c Pinch Valve to Control Inflation and Deflation of the Digit Cuff 
The micro air pump and the digit cuff were connected with silicone tubing. Inserted 
between these two components was a punch valve that was used to control the air 
flow direction within the digit cuff. When the pinch valve is opened, it lets in air from 
the micro air pump to inflate the digit cuff. When the pinch valve is pinched, it stops 
air from entering the digit cuff and releases air in the digit cuff. The block diagram of 
these three components can be illustrated below, 
tube Inlet tube 
Micro air Pinch valve Digit cuff 
pump 
Outlet tube 
Figure 3.4 - Block diagram of the digit cuff inflation and deflation mechanism 
The pinch valve is a three-way solenoid-operated device. It has two valves; one is 
normally open and the other non-nally closed. The valves' configuration will change 
over when the solenoid is energised, that is, the normally-opened valve would be 
closed and the normally-closed valve will be opened. One valve was used to control 
the tube leading from the micro air pump to the digit cuff and the other was used to 
control the outlet from the digit cuff. During the inflation of the digit cuff, the tube 
leading from the micro air pump was opened in order to allow air to enter the digit 
cuff whilst the tube that was used as an air outlet from the digit cuff was closed. 
During deflation, the tube leading from the air pump into the digit cuff was 'pinched' 
and therefore closed. At the same time, the tube leading from the digit cuff (which 
was used as an air outlet) was opened to allow air within the digit cuff to escape. 
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By controlling the way the three-way pinch valve opens and closes, different 
modulation frequencies for generating the artificial venous pulse can be achieved. 
The electronic control circuitry block diagram for controlling the pinch valve is 
shown below. 
Power 
for driving 
Pinch 
valve 
Micro- Square 
controller wave Switch 
Pinch 
valve 
Figure 3.5 - Block diagram of pinch valve control circuitry 
The microcontroller was first programmed to output a square wave at the desired 
frequency of modulation. The square wave was used to either switch on or off the 
power switch of the pinch valve. As a result, the pinch valve was switched at the rate 
of the square wave's frequency. This causes the digit cuff to inflate and deflate at that 
frequency. In this way, the venous blood volume changes can be induced by the 
inflation and deflation of the digit cuff that was wrapped at the base of the finger. The 
circuit diagram and the program listings are included in the appendix. 
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The pinch valve is a solenoid operated pinch valve and as a result, produced a lot of 
noise when it switched between configurations. The noise level was not acceptable as 
the instrument was designed to be used in a clinical environment. It was not feasible 
to encase the pinch valve in an acoustic absorber like the micro air pump as the heat 
built up in the pinch valve would cause it to stop working altogether. 
To resolve this problem, the pinch valve was modified internally such that a thin layer 
of rubber was inserted between the piston and the base of the pinch valve. The thin 
layer of rubber serves as a cushion for the piston when the pinch valve is energised. 
This modification completely eliminates the noise produced without compromising 
the pinch valve's efficiency. 
The whole design of the artificial pulse generating mechanism is encased in a metal 
box, with only an outlet for the tubing (Figure 3.6). The metal case is fitted with its 
own power supply, such that the artificial pulse generator can be powered from the 
mains. 
PPG system 
Transmission-mode 
finger probe 
Figure 3.6 - The PPG system and the artificial pulse generator 
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3.1.2 Recording of the Artificial Venous Pulsatile Signal 
The artificial venous pulsatile signal was recorded using a PPG system via a standard 
pulse oximeter transmission mode finger probe. The finger probe was first mounted 
onto the subject's index finger and the digit cuff was wrapped around the base of the 
same finger. When the artificial pulse generator was turned on, the digit cuff wrapped 
around the base of the finger will inflate and deflate at a given frequency. This would 
cause a venous blood volume change in the vascular tissue. The blood volume 
changes were then recorded along with the PPG signal by the PPG system via the 
finger probe. 
The PPG system used incorporates most features found in the standard PPG system 
such as the subtraction of ambient light through time multiplexing of the signals. It is 
also able to support six analogue channel inputs although only five are used currently. 
The PPG system is interfaced to the computer by a PLD card via a parallel link. Both 
the PPG signals and the artificial venous pulsatile signal are sampled at a rate of 
30OHz,, then digitised and fed into the computer for analysis and signal processing. 
The artificial pulse generator and the PPG system are to be used in conjunction with a 
computer during operation. The operations of the PPG system and artificial pulse 
generator can be controlled through a computer program interface. 
3.1.3 Software for Artificial Pulse Generator and PPG System 
The PPG system and the artificial pulse generator can be controlled through the PLD 
control software. The intensity of the light sources, the sampling rate and the gain of 
the PPG signal and other parameters can be specified and tuned within the software 
environment. The software used to control the PPG system and the artificial pulse 
generator was further interfaced to Matlab using Dynamic Data Exchange (DDE). In 
this way, the various parameters can be set by writing Matlab programming codes 
within the Matlab programming environment. Moreover, the data can also be 
imported directly into Matlab, ready to be analysed during operation. 
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The figure below shows the output control of the PLD software. 
Output Input 4,; ]ý Configuration 
Latching Outputs 
11 21 31 41 
Non Latching Outputs 
51 61 71 8 
o Fo ro Fo 1 Fo Fo Fo Fo 
Output Configuration 
Fv Continuously Update Output 
Synchronise Output with Input 
--- ------------- - ------------- 
-E - -'". -- -4akm* -. - 
Figure 3.6 - Output control of the PLD control software 
At present the first four latching outputs labelled, I to 4 were used for controlling the 
two intensities of the finger probe light sources and the two gains of the PPG signals. 
Non-latching output 5 was used for controlling the air pressure of the micro air pump. 
The enabling of the interrupt that would start data logging, the sampling rate of the 
analogue data and the size of the buffer were set in the input settings of the PLD 
control software as shown in the figure on the following page. 
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Input Buffer 
1256 Buffer Size (K) Clear 
E mpty Full 
Figure 3.7 - Input settings of the PLD control software 
During operation, the output and input settings were set before the Interrupt was 
enabled. The enabling of the interrupt would start the data logging process. The data 
was first stored on a memory buffer before being imported into Matlab. 
The decimation level will determine the combined sampling rate of all the channels. A 
combined sampling rate of 20001-1z was used resulting in a sampling rate of 330 Hz 
per channel. 
The different settings of the PLD control software that can be configured using 
Matlab programming codes are shown in the figure on the following page. 
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Figure 3.8 - Input and output configurations of the PLD software 
This method of setting the inputs and outputs is extremely convenient since the same 
configuration can be used repeatedly without having the need to reset them manually 
each time. 
The program listings of the Matlab program used to record the artificial venous 
pulsatile signal along with the PPG signal will be included in the appendix. 
3.2 SUMMARY 
The design of an artificial pulse generator has been outlined in this chapter, with a 
description of the different components in the design and the different electronic 
control circuitry controlling them. The use of a digit cuff in generating the pulsatile 
signal was the best method available to us. The implementation was rather 
straightforward. The use of the micro air pump and pinch valve has eliminated the use 
of an expensive system available in the market. 
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With the artificial pulse generator implemented and everything automated through 
computer control, we are now ready to conduct experiments to assess the feasibility of 
the new method in venous oximetry. In the next chapter we will look at the various 
experiments conducted to investigate this novel method of measuring venous oxygen 
saturation through venous blood volume modulation. 
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4, EXPERIMENTAL INVESTIGATION 
Various experiments involving the application of an artificial pulsation to the 
vascular tissue will be outlined in this chapter. In these experiments, both the 
arterial pulsatile signal and the artificial venous pulsatile signal were recorded. 
The objectives of these experiments were as follows: 
" The appearance and characteristic of certain terms as predicted in the 
heuristic model developed in chapter 2 will be verified against 
experimental results. 
" To explore and identify the effects of increased modulation depth on 
arterial oxygen saturation measurement. 
" Experiments were carried out to show how optimisation of the design 
could be achieved. 
" To explore and identify the effects of prolonged application of 
artificial pulse to the vascular tissue. 
The relationship of arterial oxygen saturation and venous oxygen 
saturation was explored in the simple "hold-the-breath" experiment. 
An occlusion method was used to induce a decrease in peripheral 
venous oxygen saturation whilst leaving the arterial oxygen saturation 
relatively unchanged. The experiments were conducted to verify the 
validity of peripheral venous oxygen saturation measurement by the 
new oximetry technique. 
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4.1 COMFIRMATION OF THEORETICAL RESULTS 
In chapter 2, a heuristic model of applying an artificial pulse to the venous system of 
the vascular tissue has been developed. The model separates the received intensity 
into all the possible optical paths and accounts for the DC and AC PPG signals as well 
as the artificial venous pulsatile signal, 
nT+ T+V p ý+V (A)V (t) . ...... A) =I14.1 T+ A 
j=l j 
(, Z)pj(t)+; VT+A+V(A)pj(t)_VT+A+V(A)pj(t)Vm(t) i, i 
As mentioned in chapter 2, the first two terms in the model represent the DC signal, 
the next term represents the artificial venous pulse. The next two terms are the PPG 
signal. The last term is called the multiplicative term and is the measure of the degree 
of coupling between the PPG signal and the artificial pulse; the degree at which the 
arterial system is being disturbed by the artificial pulse. The heuristic model of 
introducing an artificial venous pulse in the context of PPG signal assumes that the 
effect is both additive and multiplicative. 
The multiplicative term will be small and insignificant if the magnitude of the 
artificial pulse remains small. It is also predicted that the multiplicative term will 
appear at the frequencies of the sum and difference of the fundamental PPG signal 
frequency and the artificial pulsatile signal frequency. 
The experiments that will be outlined in this section will seek to verify the various 
predictions and assumptions made by the heuristic model against experimental data. 
In this way, the applicability of the heuristic model can be assessed. The experiment 
also acts as another way of interpreting the heuristic model. 
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4.1.1 The Artificial Pulsatile Signal has an Additive Effect 
Although the heuristic model predicted that the artificial pulse is both an additive and 
multiplicative effect, the effect is mostly additive as the multiplicative terin is small 
and insignificant as long as the magnitude of the artificial pulse remains small. An 
experiment was conducted to verify this prediction of the heuristic model. With an 
application of artificial pulsation to the venous system of the vascular tissue under 
test, the two signals (artificial pulsatile signal and the PPG signal), were recorded and 
then a Fast Fourier Transform (FFT) was operated on the recorded signals to 
transform the signals from a time domain spectrum to a frequency domain spectrum. 
This will serve to identify the different frequency components therein. If the artificial 
pulse was mostly additive, then filtering techniques should be able to separate the two 
signals. However, if the effect was mostly multiplicative, simple digital filtering will 
have a minimum effect on separating the two signals. 
The experiment was set up with the subject sitting on a chair with his left arm rested 
on a cushion at heart level. The subject was male, 28 years of age, healthy and had no 
known history of vascular diseases. The subject was asked to relax and breathe 
normally, whilst trying to keep his arm still as much as possible. A finger probe was 
mounted onto the left hand, index finger of the subject and the digit cuff was wrapped 
gently around the base (proximal phalanx) of the index finger. The PPG system was 
turned on for a period of 2 minutes without any application of artificial pulse to the 
venous system. The signals were sampled at a rate of around 330 samples per second 
and then stored for post-processing. The PPG system was turned off at the end of 2 
minutes. The second part of the experiment was conducted with the artificial pulse 
generator turned on whilst maintaining the exact settings as before. The artificial 
pulse generator modulation frequency and the peak modulation depth pressure were 
set at 6.5Hz and 100 min Hg respectively. A 2-minute sample of the signals sampled 
at the same rate as before, and recorded for post processing. The diagram on the 
following page shows the set up of the experiment 
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Figure 4.1 - Experimental Set up 
The first set of signals recorded with the artificial pulse generator turned off were 
plotted and shown on the figure below. Without any venous blood volume 
modulation, the signals recorded were just the PPG signals alone. 
PPG (IR source) 
sec 
PPG (Red source) 
0.5 
cn 
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-0.5 - 
1 1 
0 sec 6 
Figure 4.2 - PPG signals recorded in the first part of the experiment 
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In order to display the frequency components, an FFT was operated on the signals and 
Figure 4.3 shows the frequency domain of the PPG signal, 
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Figure 4.3 - PPG signals in frequency domain spectrum 
The power spectral density was estimated by taking the modulus-squared of the 
discrete Fourier Transform of the time series samples. It can be seen from the above 
frequency spectra that the PPG signals consisted of just the fundamental PPG 
frequency and its harmonics. The harmonics were present because PPG signal is not a 
perfect sinusoidal waveform. With the application of an artificial pulse, we would 
expect an additional frequency component to appear on the frequency spectra if the 
effect of applying an artificial pulse to the venous system is additive. 
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The figure below shows the signals that were recorded with the artificial pulse 
generator turned on. 
PPG (IR source) 
50 
> 
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PPG (Red source) 
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Cn 
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Figure 4.4 - Signals recorded with artificial pulse generator turned on 
It can be seen from the signals recorded above that although the signals were recorded 
with the artificial pulse generator turned on, the signals still retained a semblance of 
the PPG signals. The edges found on the pulses were caused by venous blood volume 
changes due to the artificially generated pulsation. An FFT transform was again 
operated on the time domain signals above to transform them into a frequency domain 
signals so as to identify the different frequency components. 
Figure 4.5 shows the frequency spectra of the FFT transformed signals. The power 
spectral density was estimated by taking the modulus-squared of the discrete Fourier 
Transform of the time series samples. 
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The difference between these spectra and the one on Figure 4.3 is that there is an 
additional frequency component at 6.5Hz. This additional frequency component was 
attributed to the artificial venous pulsations. The appearance of the additional 
frequency component further reinforced the notion that the effect of applying an 
artificial pulse to the venous system on the underlying natural pulsatile pulsation was 
mostly additive. 
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Figure 4.5 - Frequency spectra ol the recorclea signais wim me artiliciai puise 
generator turned on. 
The multiplicative terms that would have had appeared at frequencies 5 Hz and 8 Hz 
(sum and difference of modulation frequency, 6.5 Hz and PPG fundamental, 1.5 Hz) 
were not present or any presence would be insignificant 
due to the fact that the 
modulation depth used was small. 
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To further illustrate the fact that the artificial pulsatile signal is additive with respect 
to the underlying PPG signal, the recorded signals were made to pass through aI Oth 
order digital low-pass filter with a cut-off frequency, f, at 5Hz. The figure below 
shows the time domain plot of the low-pass filtered signals. The PPG signals 
recovered markedly resemble the PPG signals in Figure 4.2. 
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Figure 4.6 - Low-pass filtered signals of the recorded signals in Figure 
4.4 
The successful recovery of the PPG signal has shown that the effect of the artificial 
generated pulsatile signal on the underlying PPG signal is indeed mostly additive. 
Similarly, by passing the signal through a narrow band-pass filter centred at 6.5Hz, 
the artificial pulsatile signal could be recovered. 
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The figure below shows the artificial pulsatile signal recovered by passing the 
recorded signals through a narrow 4 th order digital band-pass filter with cut-off 
frequencies, f, andfc2, at 5.514z and 7.5Hz respectively. Although the modulation 
waveform was a square wave, due to the frequency response of the vascular tissue and 
the band-limited data acquisition system used, the artificial pulsatile signal resembled 
more of a sinusoid, as shown in the Figure 4.7. 
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Figure 4.7 - Artificial venous pulsatile signal 
The applicability of the heuristic model is further substantiated by this experiment, 
which proves that the effect of the artificial pulse to the arterial system is mostly 
additive. This is an important result which shows that the application of an artificial 
pulsation to the venous system will have a minimal or no effect on the arterial system 
as long as the modulation depth remains small. 
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4.1.2 The Appearance of the Multiplicative Term 
The heuristic model predicted that although the artificial pulse is mostly an additive 
effect, there is a multiplicative term which is caused by the coupling of the artificial 
pulsatile signal with the arterial PPG signal. This is deemed an undesirable effect in 
the context of venous oximetry. As explained in chapter 2, if the arterial system is 
affected, it would affect the flow of the arterial blood to the vascular tissue under test 
and thus the measurement of venous oxygen saturation would be erroneous. The 
multiplicative term in the heuristic model, 
T+A+V 
Yj (A)pj (t)v.. (t) ................................................................ 4.2 
has both the artificial pulsatile signal component and the arterial pulsatile signal 
component. Since both the two signals are small in comparison to the DC signal level, 
the multiplicative term will remain insignificant. Problems will start to arise if the 
artificial pulsatile signal component is increased, which will result in a multiplicative 
term of significant amplitude. In chapter 2, the multiplicative term was expanded by 
trigonometric identity to, 
1t+_ 
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therefore the model also predicted that the cross product or the multiplicative term 
would appear at both the sum and difference of the PPG fundamental frequency, and 
the artificial pulsatile signal frequency as in classic Amplitude Modulation theory. 
An experiment was therefore carried out to investigate the appearance of the 
multiplicative term and the frequencies that would appear as predicted by the heuristic 
model. This is important information regarding the multiplicative tenn, which will 
influence the design of venous oximeter based on the new technique. 
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The experimental set up was similar to the previous experiment with the same subject. 
The modulation depth was increased to 160 mm Hg- At this high modulation depth, 
the magnitude of the multiplicative term would become significant as a result, almost 
comparable to the I" or 2 nd harmonic of the PPG signal. 
In the experiment the peak modulation depth pressure and modulation frequency were 
set to 160 mm Hg and 6.51-lz respectively. The various signals were sampled 
simultaneously, recorded and stored in 2-minutes length duration for post analysis. 
An FFT transform was performed on the recorded signals and the frequency spectra 
are shown in Figure 4.8, 
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Figure 4.8 - Multiplicative term found on each side of the modulation peak 
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It can be seen that the artificial modulation peak was larger than the PPG fundamental 
peak as opposed to the previous frequency spectra in Figure 4.5. Other than the PPG 
harmonics, there were two other peaks are on each side of the modulation peak. This 
is the multiplicative term which is the measure of the degree at which the arterial 
system is disturbed by the artificial pulsation. The zoom-in view of Figure 4.8 is 
shown in Figure 4.9. It shows that the multiplicative term appeared at the sum and 
difference of the PPG fundamental frequency and the modulation frequency, i. e. 
classic amplitude modulation. 
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Figure 4.9 - Zoom-in figure of the multiplicative term 
The fundamental PPG frequency (which is also the heart rate) was around lHz and 
the modulation frequency was at 6.5Hz. The sum and difference of the two 
frequencies are 7.511z and 5.5Hz respectively and the multiplicative term was found at 
these frequencies. 
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The same experiment was repeated on a different subject and the frequency spectra of 
the recorded signals are shown in Figure 4.10 below, 
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Figure 4.10 - Multiplicative term was also found to be present using 
a different subject 
The experiments conducted have ascertained the applicability of the heuristic model 
and that the assumptions made in the development of the heuristic model were indeed 
valid. The mostly additive effect of the artificial pulse to the arterial system shows 
that it is possible to induce a mild perturbation to the venous system without affecting 
the arterial system. 
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This is an important conclusion as venous oximetry utilises a differential 
measurement of the absorption of light intensity (similar to that used in pulse 
oximetry), which will not be possible if the effect has been anything otherwise. The 
multiplicative term magnitude reflects the extent to which the arterial system is being 
disturbed by the artificial pulsation, thus it provides us with a means of optimising the 
modulation depth with respect to the distance away from the measurement site. The 
frequencies at which the term appears also give us a means of optimising the 
modulation frequency. The effect of the multiplicative term on the measurement of 
the arterial oxygen saturation (Sa02)will be examined in the next section. 
4.2 EFFECT OF MULTIPLICATIVETERM ON Sa02 
MEASUREMENT 
The question at this stage of the research was to what extent the effect of the 
multiplicative term had on Sa02measurement? Was the effect small and insignificant 
such that it could be ignored? An experiment was therefore carried out to study the 
effect of the multiplicative term on Sa02measurement. According to the heuristic 
model developed in the last chapter, it can be seen that the magnitude of the 
multiplicative term is dependent on the size of the PPG signal and the modulation 
depth of the artificial venous pulsation. Hence, an increase in the modulation depth 
(modulation pressure) would cause the multiplicative term to increase in magnitude as 
well. 
Five healthy subjects were used in this experiment. The subjects were between 22 and 
42 years of age with no known history of any vascular disease. The experimental 
setup was similar to the previous experiment. In the first part of the experiment, 3 
minutes of PPG signal and the artificial venous pulsatile signal using a low pressure 
modulation depth at 103 mm Hg were recorded simultaneously. In the second part of 
the experiment which was carried out immediately following the completion of the 
first, another 3 minutes of the signals were recorded but this time, with an increase in 
the modulation pressure to 113 mm Hg. 
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After a5 minutes recovery time, the two sets of experiment were repeated again, with 
the first set using the normal low-pressure modulation pressure of 103 mm Hg and the 
second set with a further increase of 10 mm Hg in the modulation depth to 123 mm 
Hg. 
Altogether, the procedure was repeated 8 times. On each occasion, the modulation 
depth of the first set was kept constant at 103 mm Hg whilst the second set's 
modulation depth was increased in steps of 10 mm Hg. 
Each two sets of experiment was analysed spectrally by performing an FFT on the 
recorded signals. The signals that were recorded were the two DC PPG signals and 
the two AC PPG signals, plus the artificial pulsatile signals. The absolute peaks of the 
fundamental PPG components in the red and infra red frequency spectra, together 
with the average DC PPG signal were used to calculate the ratio of ratios of the PPG 
signal according to the equation 1.10 as outlined in the first chapter of this thesis. 
The two ratios of ratios for the two sets of recorded signals were then used to 
calculate the percentage error according to the equations below: 
R, -R2 x 100% or x 100% ................................... 
4.4 
R, R, 
Depending on the magnitudes of R, (ratio of ratios of the first set of data) and R2 
(ratio of ratios of the second set of data), the percentage errors were then plotted 
against the modulation pressure (this is a reflection of the magnitude of the 
multiplicative term) and is shown on the graph in the following page. 
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Figure 4.11 - Effect of multiplicative term has on Sa02measurement 
It can be seen from Figure 4.11 that the percentage error increased with an increase in 
the magnitude of the multiplicative term. Due to the fact that we were modulating the 
venous system, the effective modulation pressure will be around half of the applied 
pressure. There was a sharp increase from 143 mm Hg to 153 mm Hg as the effective 
pressure used was closer to the diastolic pressure. At higher pressures, the percentage 
error was quite severe as the effective pressures were at the diastolic pressure or 
n, k above it. 
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The experimental results illustrate the point that the effect of the multiplicative term 
should not be ignored and should be taken into consideration when designing the 
instrument. Next, we will look at the ways we could optimise the design of the 
instrument by taking the magnitude of the multiplicative term and its effect into 
consideration. 
4.3 OPTIMIZATION OF THE DESIGN 
As mentioned earlier, due to the effect of the multiplicative term at high modulation 
depth, the modulation depth must be kept low in order to render the term insignificant. 
On the other hand, the magnitude of the modulation depth cannot be too small either 
as this would affect the signal-to-noise ratio of the system and thus the sensitivity and 
the effective venous oxygen saturation range of measurement. Similarly, too low a 
modulation frequency would cause the artificial pulsatile signal to fall within the PPG 
frequency band and too high a modulation frequency might cause it to fall out of the 
venous system frequency response range. 
In this section, we will describe the experiments conducted to optimise the new 
venous oximetry method in terms of the modulation frequency and the modulation 
depth with respect to the distance away from the measurement site. The multiplicative 
term becomes important in the optimisation process as it is the single, most useful 
information in determining the degree of coupling between the artificial venous 
pulsatile signal with the arterial PPG signal. 
4.3.1 Modulation Depth Optimisation 
The experimental set up was similar to the previous experiment and was conducted 
with five subjects, age ranging from 22 to 42. Both the transmission-mode finger 
probe and the digit cuff were mounted on the index finger. The distance of the 
digital 
cuff away from the measurement site was measured as the distance from the receiver 
of the finger probe to the centre of the digit cuff. 
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The artificial pulse generator was set at a particular modulation depth and signals of 2 
minutes length were recorded. After the 2 minutes interval, the experiment was 
repeated again with a small increase in the modulation depth. In total, 15 sets of data 
were recorded with the modulation depth ranging from 55mm Hg to 165mm Hg. The 
whole procedure was repeated with the distance from the measurement site to the 
digit cuff shortened. Altogether 3 different distances were used, each with 15 sets of 
data recorded. 
4.3.1 a Data Analysis of the Recorded Data 
To analyse the signal, an FFT was operated on each data set. The magnitude of both 
the modulation peak and multiplicative term were then plotted against the modulation 
depth. The figure on the following page shows the modulation peaks plotted against 
the modulation depths for three different distances away from the measurement site. 
The two vertical markers on the left and right represent the normal average diastolic 
pressure at 80 mm Hg and the normal average systolic pressure at 120 mm Hg. 
Modulation depth above the average diastolic pressure is more likely to affect the 
arterial system. If this happens, the overall blood flow to the underlying vascular 
tissue would be affected. The horizontal marker at 0.1% is known as the digital 
precision. Modulation peaks below this horizontal marker would have a poor signal- 
to-noise ratio and will be less sensitive to small changes in venous oxygen saturation. 
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Figure 4.12 - Modulation peaks versus modulation depth at three different sites 
From the above figure, it can be seen that the modulation peaks increased with an 
increase in modulation depth. There appears to be a relatively flat region between the 
two vertical markers and then a sharp rise at modulation depths above 120 mm Hg 
(right vertical marker). Similarly, as the distance of the modulation site and the 
measurement site got closer, the modulation peaks increased accordingly. 
Now let us look at the multiplicative term magnitude plot on Figure 4.13 on the 
following page. The plot shows that with an increase in modulation depth, there 
followed a parallel increase in the magnitude of the multiplicative term, as was 
predicted by the heuristic model. 
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Once again the horizontal marker, 0.01% is the digital precision at which the 
multiplicative term becomes measurable and significant in a 16-bit digital system. 
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Figure 4.13 - Multiplicative term magnitude versus modulation depth at three 
different positions 
From Figure 4.13, it can be seen that at 47mm away from the measurement site, the 
multiplicative term peaks were below the 0.01% horizontal marker at the modulation 
depths between the two vertical markers. Therefore, the upper limit of the modulation 
depth is at the pressure where the multiplicative term magnitude was at or below, the 
0.0 1% horizontal marker. 
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The lower limit of the modulation depth is the pressure at which the modulation peak 
magnitude in Figure 4.12 was at or above the 0.1% horizontal marker. By combining 
the two plots, a sketch can be made to highlight the ideal design window as on the 
figure below, 
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Figure 4.14 -A sketch to highlight the ideal design window 
for venous oximetry 
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By combining the two graphs, the ideal design window lies within the boundaries of 
the digital precision of the digital system. It highlights how the diastolic and systolic 
pressure markers, together with the pressure at each distance range where the 
multiplicative term is located, becomes significant. 
The optimisation of the new venous oximetry design pertaining to the modulation 
depth is made easier with the multiplicative term. It acts as the upper limit indicator to 
which the modulation depth could be set. The optimisation also depends on the digital 
precision that could be afforded by the digital system and the minimum sensitivity 
required of the instrument. Now we shall look at the optimisation of the modulation 
frequency. Again, we shall see that the frequencies at which the multiplicative term is 
found are important in the optimisation process. 
4.3.2 Modulation Frequency Optimisation 
The modulation frequency or the cyclic inducement of a mild perturbation to the 
venous system should be set preferably away from the PPG fundamental frequency 
and its harmonics such as to aid spectral separation through digital filtering 
techniques. The commercial pulse oximeter used a low-pass filter with a cut-off 
frequency at about 4 to 5Hz. Therefore, the pass band usually encompasses the 
fundamental PPG and the first 2 harmonics. In order to optimise the modulation 
frequency, both the modulation fundamental frequency and the multiplicative term (if 
any) should be set away from the second harmonic of the PPG signal. The frequencies 
of the multiplicative term not only depend on the modulation frequency but also on 
the PPG fundamental frequency, that is, the heart rate. 
There are two conditions which need to be satisfied during modulation frequency 
optimisation. In order to illustrate these two conditions, it helps to use a mathematical 
model for each condition to represent the PPG signal and the modulating signal. 
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The PPG signal could be modelled after a summation of sinusoidal waves, 
fH, (t) =1 fn sin(nwt + On') .................................................. 4.5 
n=I 
Where f, is the coefficient, coHRis the PPG fundamental frequency, n represents the 
harmonics (n=1 is the fundamental frequency), and OnH' is the phase involved. 
The modulating signal could be modelled in a similar fashion by the equation: - 
f, (t) = sin(co t+ 0, ) ........................................................ 4.6 
Where go is the coefficient co,, is the modulation frequency and 0,, is the phase in the 
model. 
The two conditions that need to be met for optimisation of the measurement are: 
co, n # n(coHR 
±A coHR) ................................................................................... 
4.7 
and 
w,, ± (co,, ± Aco,, ) # n(coHR± AcqHR) ........................................................... 
4.8 
where n>I 
In this way, a table can be constructed to identify the forbidden frequencies. Let us 
assume the average heart rate to be 70 and the variability is ± 10 
Forbidden frequ ncy bands 
n con for condition at (4.7) con for condition at (4.8) 
2 _ 2Hz to 2.7Hz I Hz to 4Hz 
3 3Hz to 4.05Hz 2Hz to 2.7Hz 
Therefore co,, must be at least greater than 4.05Hz but less than the digital system's 
filter upper cut-off frequency for signal detection (typically 3Hz to 6Hz). 
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Most commercial SP02 devices use low cut-off frequencies. Thus, co,, must be set in a 
narrow range of optimised band. 
Experiments were carried out to illustrate that the modulation frequencies within these 
forbidden bands will cause the multiplicative term frequency or the modulation 
frequency itself, to overlap with the first two harmonics of the PPG signal. The 
experimental set up was similar to the previous experiment. 
A modulation depth of 160 min Hg was chosen so as to induce a multiplicative term 
that was of significant magnitude, and which was also comparable to the first two 
harmonics of the PPG signal. The PPG system and the artificial pulse generator were 
switched on for 2 minutes and the modulation frequency was set at 4Hz. During these 
2 minutes, the PPG signal and the artificial venous pulsatile signal were recorded. The 
systems were then turned off for 2 minutes before the whole experiment was repeated 
again; this time, however, with the modulation frequency increased to 4.5Hz. 
The experiment was repeated with an increase of modulation frequency in steps of 0.5 
Hz until 6.5Hz. The plots on the following pages are the power spectrums of the PPG 
signal with venous modulation at various frequencies. 
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Figure 4.15 - Frequency spectrum of signals with modulation frequency at 4Hz 
In Figure 4.15, the first harmonic (n=2) of the PPG signal overlaps with the 
multiplicative term and the modulation fundamental frequency overlaps with the 2 nd 
harmonic. A 4Hz modulation frequency fails both the conditions set out earlier. This 
would pose a problem should the signals be spectrally separated between two signals. 
Furthermore, in optimising the modulation depth, the magnitude of the multiplicative 
term is important in determining the degree of coupling between the two signals. The 
overlapping of the multiplicative term with PPG hannonics would cause erroneous 
measurements of the magnitude. 
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Figure 4.16 - Frequency spectrum of signals with modulation frequency at 4.5Hz 
In Figure 4.16, at 4.514z, the multiplicative term starts to move away from the first 
harmonic but the modulation frequency remains dangerously close to the 2d 
harmonic. 
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Figure 4.17 - Frequency spectrum of signals with modulation frequency at 5Hz 
Figure 4.17 illustrates the situation when the heart rate is increased. Although the 
modulation frequency has increased to 5Hz, the multiplicative term and modulation 
fundamental frequencies still overlap the I" and 2 nd harmonics respectively. This 
result shows that the optimisation process also depends on the heart rate variability. 
Although we could still increase the frequency further, it should be noted that the 
venous compliance of an elderly person will be less than that of a young adult and 
therefore higher frequencies might cause the venous blood volume modulation to fail 
to register completely. 
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In such cases, the optimisation will be solely on the modulation depth alone so as to 
ensure that the multiplicative term is small and relatively insignificant as compared to 
the harmonics of the PPG signal. 
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Figure 4.18 - Frequency spectrum of signals with modulation 
frequency at 5.5Hz 
When the modulation frequency was increased to 5.5Hz, the multiplicative term was 
too close to the 2 nd hannonic of the PPG signal to facilitate separation of the two 
signals through filtering. Figure 4.19 on the following page shows the frequency 
spectrum of the signals recorded when the modulation 
frequency was at 6Hz. It can 
be seen that both the multiplicative term and the modulation 
frequency have moved 
out beyond the 2 nd hannonic region of the 
PPG signal. 
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Figure 4.19 - Frequency spectrum of signals with modulation frequency at 6Hz 
Due to the variability of the heart rate, it is essential to maintain an isolating band 
between the second harmonic and the multiplicative term. The frequency spectrum of 
the signals recorded with the modulation frequency set at 6.5Hz in Figure 4.20 shows 
that the multiplicative term has moved away from the 3 rd harmonic of the PPG signal. 
This creates an isolating band between the 2 nd harmonics and the multiplicative term. 
In cases where the heart rate of the patient does not fluctuate greatly, a narrower 
isolating band can be used instead. 
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Figure 4.20 - Frequency spectrum of signals with modulation frequency at 6.5Hz 
The optimisation of the modulation frequency once again depends on the 
multiplicative tenn as well as the heart rate of the sub ect. Due to the proximity of the j 
multiplicative term with the harmonies and the variability of the heart rate, the 
optimisation process will result in a fairly narrow frequency band. 
Using a lower frequency other than the optimized frequency might be possible if the 
modulation depth applied is such that the multiplicative term remains small and 
insignificant compared to both the PPG signal and artificial pulsatile signal. With both 
the modulation depth and frequency optimised, it is time to look at the physiological 
effect, if any, of prolonged application of artificial pulsatile signals on the vascular 
tissue under test conditions. 
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4.4 PROLONGEDAPPLICATIONof ARTIFICIAL PULSE 
The application of artificial pulsatile signal to the venous system (so as to induce a 
mild perturbation in the venous blood) in order to measure the oxygen saturation of 
the venous blood through differential measurement, is intended to be a continuous 
method. The prolonged application of the artificial pulse will be inevitable if the 
measurement is continuous. There is the potential risk that with prolonged application 
of the artificial pulse, venous pooling might occur and this will affect the venous 
oxygen saturation ý71,721 . This 
is important as pressure-induced ischemia might lead to 
[73] localized necrosis 
In normal conditions, prolonged applications of artificial pulsation in the venous 
system cause venous pooling and affect normal tissue oxygenation. An experiment 
was conducted to access this risk and to throw some light into this issue. The 
experimental set up was similar to the previous experiment; the subject was 28 years 
of age, with no known history of any vascular disease. He was placed in a sitting 
position with his left arm rested on a cushion at heart level. The PPG probe was 
mounted on the index finger of the left hand and the digit cuff was wrapped around 
the proximal phalanx of the same finger. The artificial pulse generator was turned on 
for 30 minutes and the signals via the finger probe were recorded. The modulation 
frequency and the modulation depth were set at 6.5Hz and 100 mm Hg respectively. 
The recorded signal was analysed by breaking the recorded signal into 30 sets of data, 
each one minute in length. An FFT was performed on each set of data, and the 
absolute power of the PPG fundamental frequency peak, the modulation frequency 
peak and the mean value of the mean DC value for each source were used to compute 
the ratio of ratios which is related to the oxygen saturation. The ratio of ratios was 
calculated each for the PPG signal and the artificial venous pulsatile signal using the 
formula, 
R= 
C, ý, / DCj, 
......................................................... 
4.9 
AC 'ý2 IDC'12 
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where AI and ý2were the red and infra red light sources respectively. For the arterial 
PPG signal, 28 sets of ratio of ratios were calculated as two sets of data were 
discarded due to movement artefacts. The mean value of the ratio of ratios was 0.3768 
(SD ± 5.6%). 
Similarly, for the ratio of ratios of the artificial venous pulsatile signal, 28 sets were 
included in calculating the mean and standard deviation. The mean value of the ratios 
of ratios was 0.5127 (SD ± 4.7%). Figure 4.21 shows the plot of the ratio of ratios of 
the two signals and the mean value for each. 
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Figure 4.21 - Ratio of ratios plot for both PPG and artificial pulsatile signals 
The mean value of the artificial pulsatile signal's ratio of ratios was greater than that 
of the PPG signal due to the fact that the oxygen saturation 
in the venous blood was 
less than the arterial oxygen saturation. 
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The result was in-line with our expectation; after the tissue has extracted the oxygen it 
needs from the arterial blood, this will cause a reduction in the oxygen saturation in 
the venous blood as discussed in chapter 1, section 1.3.1. The small variance shows 
that the prolonged application of a mild perturbation to the vascular tissues has little 
or no significant effect on tissue oxygen extraction. The modulation frequency used 
was far below the average time (15 seconds) required by the haemoglobin 
concentration to respond to the venous occlusion [74] .A separate experiment conducted 
by T. Rooke et al. involving the use of a pneumatic cuff on the lower limbs had 
concluded that skin blood flow was augmented in ischemic limbs by intermittent 
venous occlusion method [75] . 
The experiment has shown that the risk of venous pooling in prolonged applications 
of mild perturbation to vascular tissue is small. It does not have a significant effect on 
tissue oxygen extraction. 
Next, we shall look at the relationship between arterial oxygen saturation and venous 
oxygen saturation. The hypothesis was that if we were truly measuring venous oxygen 
saturation, then we would expect the measured venous oxygen saturation to reduce if 
arterial oxygen saturation was reduced. The next experiment to be outlined was set 
out to prove this hypothesis. 
4.5 RELATIONSHIP BETWEEN Sa02 AND 
SV02 
The relationship between arterial oxygen saturation and venous oxygen saturation 
is 
intimately linked. As discussed in chapter 1, a reduction in arterial oxygen saturation 
will cause venous oxygen saturation to be reduced if tissue oxygen extraction 
remained relatively unchanged. 
The experimental set up was again, similar to the previous experiment and 
3 different 
Subjects were used with an average age of 
25. Each subject was asked to hold his 
breath for as long as he possibly could. 
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The experiment was repeated with a5 minute interval for each subject. Altogether 3 
sets of the same experiment were conducted for each subject. The length of each 
recorded signal was about I to 1.5 minutes in length. Each set of recorded data was 
then broken up into data sets of about 20 seconds in length. An FFT transform was 
operated on each 20 seconds length of data set. The absolute power peaks of the PPG 
fundamental frequency, modulation frequency and the mean DC value for each light 
source were used to calculate the ratio of ratios. Two ratio of ratios were calculated; 
one for the PPG signal and the other for the artificial venous pulsatile signal. Figure 
4.22 shows the artificial pulsatile signal's ratio of ratios plotted against the ratio of 
ratios for the PPG signal. 
Desaturation Experiment 
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The simple hold-the-breath experiment was not a proper desaturation test but the 
result did establish a relationship between arterial oxygen saturation and venous 
oxygen saturation. In the plot in Figure 4.22, as the arterial saturation decreased, 
venous oxygen saturation also decreased. With the reduction in arterial oxygen 
saturation and with an unchanged demand for oxygen by the tissues, the venous 
oxygen saturation was reduced since there was less oxygen in the blood to begin with. 
A different experiment (which will be discussed with more details in the next section), 
was conducted to induce a reduction in the peripheral venous oxygen saturation 
without affecting the arterial oxygen saturation. The objective of this experiment was 
to prove that what we were measuring was indeed venous oxygen saturation. 
4.6 Svo, REDUCTION INDUCED BY VENOUS OCCLUSION 
An experiment was conducted to verify that the measurements we made were indeed 
venous oxygen saturation. Although a change in the venous oxygen saturation can be 
brought about by a change in the arterial oxygen saturation, there is always the 
potential danger that we might be just measuring a secondary measurement of the 
arterial oxygen saturation. Therefore, an experimental protocol was devised to induce 
a change in the venous oxygen saturation whilst leaving the arterial oxygen saturation 
relatively unchanged. One way of doing this was described in an experiment by 
Nitzan et al. Although the experiment detailed a method to measure the oxygen 
saturation by applying a relatively low external pressure of about 25 mm Hg to the 
forearm, it also concluded that venous occlusion also reduced venous oxygen 
saturation because of the ongoing de-oxygenation of the blood due to lower blood 
flow [76] .A separate study 
by Casavola C et al. on the effect of time of inflation and 
pressure on tissues oxygen consumption 
[74] arrived at the same conclusiong namely 
that different levels of oxygen consumption at the calf muscle could be induced 
through venous occlusion. 
CHAPTER 4 97 
EXPERIMENTAL INVESTIGATION 
The subject was a healthy 28 year-old male, with no known history of any venous 
disease. A pneumatic pressure cuff attached to an aneroid sphygmomanometer was 
wrapped around the upper arm (brachialis muscle) of the subject, just above the 
elbow. The digit cuff was wrapped around the base of the index finger (proximal 
phalanx) of the same arm. A transmission-mode PPG finger probe was also attached 
to the fingertip of the same index finger. At the start of the experiment, the pulse 
generator (set at 6.5Hz) was switched on at the same time the PPG system started to 
acquire data. The pressure cuff on the upper arm remained deflated until 30 seconds 
into the experiment where it started to inflate until it exerted a pressure of 30 mm Hg 
at the upper arm. It took approximately 10 to 15 seconds to inflate the cuff to the 
required pressure of 30 mm Hg. The cuff was then made to deflate 30 seconds after 
the cuff had started to inflate. A timeline for the protocol is shown in the figure below. 
Artificial Pulse Generator started -- 0 sec 
Data acquisition started 
Inflation started 30 secs 
Deflation started 60 secs 
Data acquisition stopped 
Artificial Pulse Generator stopped 1 120 secs 
Figure 4.23 - Timeline of the protocol for the experiment 
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In this experiment, a pressure of 30 mm Hg would cause venous pooling in the arm 
but the low pressure would not obstruct arterial inflow. Due to lower blood flow,, the 
venous blood would be subjected to ongoing de-oxygenation, whereas the arterial 
oxygen saturation would remain relatively unchanged. With this protocol, we would 
expect the venous oxygen saturation within the time when the pressure cuff at the 
upper arm was inflated, to reduce and then return to its normal level after the pressure 
cuff was released. 
The experiment was 120 seconds long. The data analysis consisted of separating the 
PPG signal and the venous modulation signal spectrally. The data collected was 
filtered using a bandpass filter to extract the low frequency PPG signal. The artificial 
venous pulsatile signal was extracted using a narrow bandpass filter centred on the 
modulation frequency of the artificial pulse generator. The DC signals for both 
sources (namely, red and Infrared) were also extracted using lowpass filter. 
Both the extracted AC PPG signal and the AC venous modulation signal were made 
to pass through an envelope detection algorithm which will trace the envelope of the 
waveform. The envelope detection algorithm was used to calculate the peak-to-peak 
values of the AC signals. The algorithm would first trace the peaks of the waveform 
and then the troughs; the difference of which would yield the peak-to-peak values. 
The values of the DC signals and the peak-to-peak values of the AC signals were then 
used to fon-nulate the ratio of ratios which is related to the oxygen saturation of the 
blood. Figure 4.24 shows the AC artificial venous pulsatile signal from the Infrared 
source that was extracted by filtering the recorded signal with a narrow bandpass filter 
centred at the modulation frequency. Figure 4.25 shows the envelope detected by the 
envelope detection algorithm. 
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Figure 4.25 - Envelope of the AC venous modulation signal from the 
infrared source 
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The AC peak-to-peak values were calculated by subtracting the troughs (bottom 
waveform. in Figure 4.25) from the peaks (upper waveform in Figure 4.25). With 
these peak-to-peak values, the ratios of ratios of both the PPG signal and the artificial 
venous pulsatile signal were then fonnulated according to equation 4.9. 
In the experiment, the PPG signal ratio of ratios remained fairly constant with a mean 
of 0.6729 (SD ± 2%, variance 1.8965 x 10-4) . This value was higher than previously 
measured in other experiments because an envelope detection peak-to-peak 
measurement method was used here as opposed to an FFT method. The absolute value 
of the ratio of ratios was not important at this stage as the instrument was not 
calibrated yet. The important observations in this experiment are that the ratio of 
ratios of the PPG signal remained relatively unchanged, whilst there was a significant 
change in the ratio of ratios of the artificial venous pulsatile signal during the time 
when venous occlusion pressure was applied to the upper arm. The ratio of ratios of 
the artificial pulsatile signal which was related to the venous oxygen saturation was 
plotted against time as shown in the figure below, 
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Figure 4.26 - Ratio of ratios of the artificial venous pulsatile signal 
It can be seen from Figure 4.26 that there was a 
big change in the ratio of ratios within 
the 30 to 60 sec time window when the cuff was exerting a pressure of 30 mm 
Hg on 
the upper arm. 
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This shows that the reduction in venous oxygen saturation induced by venous pooling 
was correctly detected by the artificial venous pulsatile signal. The fluctuations in the 
values were greater after the cuff had been released than before the cuff was inflated. 
This could be due to sloshing of the venous blood when the cuff was suddenly 
released. 
Figure 4.27 shows the decrease in the venous oxygen saturation from the perspective 
of the raw data and the Infrared spectrum of the artificial venous pulsatile signal. 
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Figure 4.27 - Decrease in venous oxygen saturation 
from the perspective of the 
raw data and the artificial venous pulsatile signal 
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During the event when the cuff was inflated and exerted a low pressure of 30 mm Hg 
on the veins, it can be seen from Figure 4.27 that this event coincided with the 
narrowing of the artificial venous pulsatile signal AC peak-to-peak value in the 
Infrared source. The significant change in the AC peak-to-peak values provided us 
with some level of confidence that the significant change in the ratio of ratios was not 
created due to complex analysis of the raw data. 
The experiment was repeated twice, each with a slight change to the initial protocol 
used; the time when the pressure cuff started to inflate was changed to the 40th second 
and then to the 5 Oth second. In both cases, the period of reduction in venous oxygen 
saturation coincided with the time when the venous occlusion was applied to the 
upper arm. Figure 4.28 shows the artificial venous pulsatile signal's ratio of ratios at 
three different periods of venous occlusion. 
In this experiment, the new venous oximetry technique was able to correctly detect 
the reduction in venous oxygen saturation in those periods where venous occlusion 
was applied to the upper arm. Since the inducement only affected the venous oxygen 
saturation and not the arterial oxygen saturation, the increase in the ratio of ratios 
derived from the artificial pulsatile signals could only be a reflection of the level of 
venous oxygen saturation and not a secondary arterial oxygen saturation 
measurement. 
The reduction in venous oxygen saturation only appeared as a peak within the narrow 
time window. This was due to the fact that the average time required 
for the 
haemoglobin to react to venous occlusion is about 15 seconds 
[74] 
. The 
double peaks at 
the third set was purely due to experimental errors since when the cuff was 
inflated to 
30 mrn Hg, it would then start to reduce a little. The second peak might 
be due to the 
effect of pumping the cuff back to 30 mm Hg 
in the course of the experiment. 
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three different 
periods of venous occlusion 
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4.6.1 SV02 reduction induced by different venous occlusion 
pressures 
In the previous experiment, the time the pressure cuff on the upper arm started to 
inflate was varied in order to induce a reduction in peripheral venous oxygen 
saturation at different points in time and the new venous oximetry technique was then 
used to detect these changes at those points in time. In this experiment, the venous 
occlusion pressure was varied so as to induce different levels of reduction in 
peripheral venous oxygen saturation. The experimental setup was similar to the 
previous experiment. The pressure cuff was wrapped around the upper arm of the 
subject and the PPG probe and digit cuff were mounted on the index finger of the 
same arm. Initially, the PPG signal and artificial pulsatile signals were recorded for a 
period of 3 minutes with the pressure cuff at the upper arm remaining deflated. This 
initial period of recording was to establish the baseline of theSV02before any venous 
occlusion was applied to the upper arm. After the initial period of recording, the 
pressure cuff was inflated to 20 mm. Hg. After a minute had elapsed whereby the cuff 
remained inflated at 20 mm Hg, the PPG signal and the artificial pulsatile signals 
were recorded for a period of 3 minutes. 
The whole procedure was repeated with an increase in venous occlusion pressure of 5 
mm Hg to 25 mm Hg after a5 minutes recovery time. Altogether, the procedure was 
repeated 7 times with different venous occlusion pressures applied to the upper arm 
ranging from 20 mm Hg to 50 mm Hg in steps of 5 mm Hg each time. 
For every venous occlusion pressure two sets of signals were recorded; one when the 
pressure cuff remained deflated and the other when the occlusion pressure of the 
pressure cuff on the upper arm was set at a 
desired level. An FFT was operated on 
these two sets of recorded signals in order to measure the absolute power peaks of the 
PPG fundamental frequency, modulation frequency and the mean DC value for each 
light source. These values were then used to calculate the ratio of ratios. 
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By comparing the twoSV02 ratio of ratios in these two sets of recorded signals, we 
would be able to determine the levelOfSVO2 reduction that was caused by the venous 
occlusion pressure applied to the upper arm indirectly by calculating the percentage 
increase in theSV02ratio of ratios, 
R, -R, xloo% ........................................................ 4.10 R, 
where R, is the SV02 ratio of ratios baseline and R2 is the SV02 ratio of ratios 
measured with venous occlusion pressure applied to the upper arm. Figure 4.29 shows 
the percentage increase inSV02 ratio of ratios at different venous occlusion pressures. 
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Figure 4.29 - (Subject A): different 
levels of venous oxygen saturation reduction 
induced by different venous occlusion pressures. 
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Following informed full consent, the experiment was repeated on another subject. The- 
results of the experiment are shown in Figure 4.30. 
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Figure 4.30 - (Subject B): different levels of venous oxygen saturation reduction 
induced by different venous occlusion pressures 
From Figures 4.29 and 4.30, it can be seen that the venous oxygen saturation at the 
index finger gradually decreased with an increase in venous occlusion pressure. In 
both cases, the PPG signal's ratio of ratios or the indirect measurements of arterial 
oxygen saturation level remained fairly constant throughout with a standard deviation 
below ±6%. 
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The arterial system was not affected as the venous occlusion pressures used were well 
below normal diastolic pressure; Casavola C et al. had also arrived at the same 
[74] 
conclusion when performing venous occlusion at the human calf muscle 
In their experiment it was also found that oxygen consumption of the muscles 
increased (i. e. a decrease in peripheral venous oxygen saturation) with an increase in 
venous occlusion pressure, but this relationship broke down when the venous 
occlusion pressure was above a certain critical pressure. Although the percentage 
increase inSV02 ratio of ratios was much less in subject B- probably due to a higher 
mean blood pressure, both graphs have a rather similar bell-shaped curve. In our 
experiment we found that venous oxygen saturation did not decrease further but 
actually increased when the pressure applied was between 40 to 45 mm Hg for subject 
A and 50 to 55 mm Hg for subject B. The results are similar to the findings of 
Casavola C et al. 
The experiment has demonstrated that the new method of venous oximetry can detect 
changes in the venous oxygen saturation that was induced by different venous 
occlusion pressures. It has proved that the measurement we were making was indeed 
the venous oxygen saturation and not some kind of secondary arterial oxygen 
saturation measurement. 
4.7 CONCLUSION 
Altogether, six different experiments with different ob ectives were conducted in this j 
research. Each experiment was designed to answer some of the questions regarding 
the feasibility of the new method of venous oximetry. The verification of the heuristic 
model as developed in chapter 2 was adequately proven 
in the first experiment in 
regards to the additive nature of the artificial venous pulsatile signal to the underlying 
PPG signal and the appearance and the frequency location of the multiplicative term 
at high modulation pressure. 
All these features that were predicted in the heuristic 
model were shown to 
be true and proven adequately in the experiment. 
PTER 4 108 
EXPERIMENTAL INVESTIGATION 
The effect of the multiplicative term had on Sa02measurement was assessed in the 
next experiment and the results shown that the effect was quite significant when the 
magnitude of the multiplicative term was increased. The experiment concluded that it 
is essential that the multiplicative term and its effects are taken into consideration 
when designing the new venous oximeter. 
By exploiting the multiplicative term, it is possible to optimise the design of the new 
method of venous oximetry. The next experiment was conducted to optimise the 
modulation frequency and the modulation depth. 
One part of the experiment was conducted to optimise the modulation frequency with 
respect to the PPG signal, its harmonics and the multiplicative term frequency. The 
second part of the experiment was conducted to optimise the modulation depth with 
respect to the magnitude of the multiplicative term. The combination of the two 
yielded an ideal design window in terms of modulation frequency and depth. The 
optimisation would ensure the best possible accuracy and sensitivity to venous 
oxygen saturation measurement. 
The next experiment was conducted to explore the effects of prolonged application of 
the artificial pulse to the venous system on the measurement of venous oxygen 
saturation. 
The experiment was conducted over a significantly long period of time to establish 
the fact that prolonged application of the artificial pulse would not cause venous 
pooling and thus affect the venous oxygen saturation measurement. 
This is important 
as the new method of venous oximetry is designed to monitor venous oxygen 
saturation in real time. The experiment concluded that prolonged application of 
artificial pulse to the venous system would not 
have an effect on venous oxygen 
saturation measurement. 
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The next three experiments were conducted to verify that the measurements taken 
were indeed related to the venous oxygen saturation and not just perhaps a secondary 
measurement of the arterial oxygen saturation. There exists a relationship between the 
arterial oxygen saturation and venous oxygen saturation. If the tissue metabolism 
remains unchanged, a reduction of arterial oxygen saturation would lead to a 
reduction in the venous oxygen saturation too. This is simply because there is less 
oxygen in the blood to begin with. A simple experiment was conducted to reduce the 
oxygen supply to the arterial blood by holding one's breath. The reduction in arterial 
oxygen saturation reduced the venous oxygen saturation globally and this was 
reflected in the measurement taken. 
The experimental results have shown that there exists a relationship between the 
arterial oxygen saturation and the venous oxygen saturation measured using the new 
venous oximetry technique. 
The second experiment was conducted to induce a reduction in the venous oxygen 
saturation locally without affecting the arterial oxygen saturation. The pressure cuff 
occlusion method on the upper arm was used to induce a reduction in venous oxygen 
saturation locally. 
The experimental results have shown that the period where the venous oxygen 
saturation was reduced coincided with the time the cuff was inflated during which, the 
arterial oxygen saturation remained fairly constant. 
The third experiment was an extension to the last experiment whereby the pressure of 
venous occlusion was varied instead of the time of cuff inflation. 
By varying the 
venous occlusion pressure, different levels of venous oxygen saturation reduction 
could be induced. This was to test whether our 
instrument could faithfully detect those 
changes in the level of venous oxygen saturation. 
Once again, our instrument proved 
to be up to the task. 
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The experiments conducted and outlined in this chapter have proved that it is feasible 
to measure the peripheral venous oxygen saturation by introducing an artificial 
pulsatile signal to the venous system. 
A venous oximetry instrument that is designed based on this new method could be 
calibrated in the same way as conventional pulse oximeter. 
In conclusion, the new method of measuring venous oxygen saturation is based on a 
sound heuristic mathematical model that can be interpreted through experimental 
data. The experimental results of various experiments conducted have that artificial 
pulse based venous oximetry is a promising new technology poised to replace 
invasive monitoring of venous oxygen saturation in the near future. 
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CONCLUSION / DISCUSSION 
The primary objective of this thesis has been to investigate the possibility of 
measuring peripheral venous oxygen saturation by introducing an artificial 
pulsatile signal to the venous system such that a differential measurement, 
similar to the one used in pulse oximetry, could be used to derive venous blood 
oxygen saturation. A heuristic mathematical model with respect to the artificial 
pulsatile signal was developed and experimentally justified. The side bands or 
the multiplicative term within the model played an important role in the 
optimisation of the design with respect to the distance of modulation from the 
measurement site, the modulation frequency and the modulation depth. The 
non-invasiveness of the measurement could be used to replace the existing 
invasive method which involves catheterisation. In this chapter we will discuss 
the applications of this technique, future improvements and developments to 
the new venous oximetry technique. 
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5.1 CONCLUSION 
Clinical monitoring of venous oxygen saturation has been impeded by its invasive 
method involving catheterisation and as such it comes with the complications that 
might arise with catheterisation. Venous oxygen saturation monitoring provides vital 
information on assessing a patient's oxygenation. Its use in clinical environments 
would have a greater impact on medical care if it is more widely adopted. The main 
obstacle standing in the way for venous oximetry in achieving its full potential is its 
invasive nature. The aim of this thesis has been to devise a new non-invasive method 
of venous oximetry that we hope, in the future, could replace the existing invasive 
method, without compromising the accuracy and sensitivity to real time changes in 
venous oxygen saturation. 
Pulse oximetry uses the natural arterial pulsations to separate the absorption due to 
arterial blood from other static or quasi-static components in the finger such as the 
tissues, bone and venous blood. Hypothetically, if there is a pulsation that is 
associated with the venous blood and its characteristic is different from the natural 
arterial pulsation, then it would be possible to separate the absorption due to the 
venous blood from all other components in the finger. With this hypothesis, we 
further developed the means to induce an artificial pulsation in the venous system. 
In order to investigate the physiological effects that the artificial pulse has on the 
underlying tissues, especially on the underlying arterial pulsations, we 
developed a 
heuristic model that is based on a model of photoplethysmography that was 
interpreted previously by using both the Beer-Lambert law and the diffusion theory. 
In the model, the multiplicative term is a function of both the PPG signal term and the 
modulation signal term. It will therefore remain small 
if the modulation depth is 
small. The heuristic model was then 
interpreted using the Beer-Lambert law and later 
justified through experimental results. 
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The frequency and the magnitude of the multiplicative term were also used to 
optimise the design of the new venous oximetry method. Experiments were conducted 
to optimise the modulation frequency and the modulation depth with respect to the 
distance from the measurement site. Although the multiplicative term is an 
undesirable effect which should be minimised as much as possible, it does provide us 
with a means to optimise the design. 
The results from the various experiments conducted have clearly shown that the new 
method of venous oximetry was indeed feasible and has the potential to be developed 
into a non-invasive method of monitoring venous oxygen saturation in a clinical 
environment. 
5.2 FUTUREAPPLICATIONS 
In this section, we shall look at a few applications of this artificial pulse-based venous 
oximetry method. Applications of injecting an artificial pulse into the venous system 
as well as the new method of venous oximetry will be discussed. 
5.2.1 Venous Diagnosis 
Venous Occlusion Plethysmography (VOP) is the measurement of changes in tissue 
volume in response to the temporary obstruction of venous return. It is used clinically 
to measure certain physiological conditions of blood vessels such as venous 
capacitance. VOP relies on the principle that the occlusion of venous return causes a 
slight swelling of distal portion of the tissue under test 
due to continued arterial 
inflow. The changes of venous blood volume over time during VOP is illustrated 
in 
Figure 5.1. 
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Figure 5.1 - Venous blood volume changes during VOP measurement 
The slope of the volume change ((x) following occlusion, is used to measure arterial 
blood flow. AV can be used to measure the venous capacitance. Other parameters that 
can be measured using VOP are venous outflow and venous compliance. 
The current VOP methodology involves an examination of the step response of the 
venous system. The new method described in this thesis offers a different 
methodology in which the frequency response of the venous system is examined. 
Generally, we would expect healthy veins to have a higher frequency response as in 
having a higher cut-off frequency than unhealthy, calcified veins. 
The implications of using this methodology in VOP are yet to be established. Further 
research would need to be carried out in this area in order to ascertain the viability of 
this new methodology in diagnosing the venous system. 
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5.2.2 Physiological Control of a Totally Artificial Heart 
Mixed venous oxygen saturation has been proposed as one of the suitable parameters 
for the physiological control of a totally artificial heart. In a study by Nakamura et al., 
by monitoring mixed venous oxygen saturation (SV02) and cardiac output (CO) of a 
calf during a three-stage step treadmill exercise test, it was found that there existed a 
[77] linear correlation between the magnitude of changes in CO and SV02 . CO and 
SV02exhibited a similar course of change, expressing an inverted exponential curve. 
In order to develop a practical artificial heart that could give the user mobility, it is 
essential to be able to monitor SV02 in a ready and prompt manner. This would be 
made easier ifSV02 could be monitored non-invasively. The new method of venous 
oximetry proposed in this thesis could be further developed and miniaturised in order 
to monitorSV02 "on-the-go", thereby controlling CO of the artificial heart in real time 
and affording the user mobility. The development of a totally artificial heart is still in 
its infancy; much research and development would need to be done in this area to 
determine the best way to control it. If SV02 proved to be the best way, then the 
development OfSV02monitoring would move in the direction of being non-invasive 
and portable. 
5.3 SUGGESTION FORFUTURE WORK 
This section outlines the author's suggestions on future work in this area. 
Some of the 
possible applications of the method will be 
discussed in detail. Trials that could be 
conducted to further verify the feasibility of the method to 
be used in clinical 
environments, experiments and 
hardware designs that could improve the usability of 
the instrument will also be described in this section. 
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5.3.1 Calibration 
The new method described in this thesis concerns the measurement of peripheral 
venous oxygen saturation in the finger. The existing method of measuring venous 
oxygen globally is through the catheterisation of the pulmonary artery. More recently, 
the central venous catheter has been used instead as central venous oxygen saturation 
(SCV02), is obtained in a less risky and costly manner 
ý78] 
, and can offer an attractive 
alternative toSV02monitoring. Although the oxygen saturation values for these two 
cases would be different, in one study, SV02 could be estimated with great accuracy 
throughSCV02by using a power modd 16] . 
In a similar way, it is hoped that SV02 could be estimated through peripheral venous 
oxygen saturation at the finger. In order to do this, an investigation would need to be 
carried out that would calibrate the new method toSV02. It would also be interesting 
to find out what is the relationship between SV02 and peripheral venous oxygen 
saturation in the finger. The calibration process would involve subjects breathing 
through a spirometer; a calibration method similar to that used for the pulse oximeter. 
Periodic blood sampling and analysis would also be carried out. This new method of 
venous oximetry can be calibrated due to the fact that it uses differential measurement 
similar to that used in pulse oximetry. 
If the calibration process proved to be successftil and clinical trials proved that SV02 
could be estimated accurately through peripheral oxygen saturation measured at the 
finger tip, then this new method could replace the existing invasive method and 
reduce the risk and complication involved with continuous invasiveSV02monitoring. 
Controversial issues surrounding SV02monitoring include the cost effectiveness of 
using the special 
SV02 catheter over the normal pulmonary catheter 
[79,80] 
as the fibre 
optic SV02 catheter costs much more than a normal catheter. With the introduction of 
this new method of venous oximetry, the cost of continuous monitoringOfSV02could 
be significantly reduced as the new method eliminates the use of special catheters. 
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5.3.2 Clinical Trial 
A clinical trial would need to be conducted on real patients, especially patients 
undergoingSV02monitoring through pulmonary artery catheterisation. In this way we 
could compare the measurement between using the new method of artificial pulse- 
based venous oximetry and the invasive method of pulmonary artery catheterisation. 
The measurements should also be compared to samples of blood taken from the 
pulmonary artery. During the clinical trial, the performance of the new method of 
venous oximetry could be assessed and improvements in areas like signal processing 
or mechanical designs of the instrument could be fine-tuned accordingly. Feedback 
from the patients and clinicians regarding the instrument could also help in designing 
the instrument to be more user-friendly. 
Clinical assessment of the new instrument is valuable in determining the accuracy and 
sensitivity of the instrument to changes in the venous blood oxygen saturation. The 
instrument would need to be able to reflect a change in the venous blood saturation 
within a relative short period of time so as to allow clinicians enough time to direct 
therapies accordingly. 
Clinical trials would also provide us with a means to find out under what 
circumstances would the instrument fail. Although adequate experiments have been 
conducted to assess the instrument's feasibility in measuring peripheral venous 
oxygen saturation, real patients were never used as subjects. Therefore there might 
arise conditions during the trial that could affect the performance of the instrument. 
In order for the instrument to be adopted in clinical environments, the application of 
clinical trials is a vital step for reaching that goal. The trials will lead to modification 
and fine-tuning of the instrument, thereby making it more suitable for use in a clinical 
environment. It is also hoped that clinical trials will lead to the endorsement of the 
new instrument by clinicians. 
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5.3.2a Preliminary Clinical Trial I 
A preliminary clinical trial was conducted at the cardiothoracic surgical department in 
Glenfield hospital. With the approval from the ethics committee and full consent from 
the patient, a clinical trial was carried out to compare the patient's Cardiac Output 
(CO) measured using the traditional Swan-Ganz thermodilution method with the new 
venous oximetry measurement. 
A 66 year-old woman was undergoing a mitral and tricuspic valves repair operation. 
Due to her low CO, an Intra-Aortic Balloon Pump (IABP) was inserted into the aorta 
to improve the CO of the patient. Figure 5.2 shows theSV02 ratio of ratios waveform. 
that was recorded before and after the IABP was inserted. 
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Figure 5.2 - Improvement inSV02after IABP was inserted. 
Before insertion of the IABP, the patient's CO was 2.4 I/min as measured by Swan- 
Ganz thermodilution method. When the IABP was first inserted, it caused a transient 
decline inSV02as shown in the sharp rise inSV02 ratio of ratios at the 2 
nd minute on 
Figure 5.2. When the pump was turned on and the IABP was fully operational, the 
CO 
of the patient was 
increased to 4.42 I/min and this improvement in CO was reflected 
in the SV02 ratio of ratios waveform that was recorded 
by the new venous oximetry 
technique. 
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The results in this preliminary clinical trial were quite promising as it shows that the 
new venous oximetry technique was able to trace the improvement in CO by 
reflecting an increase inSV02peripherally. 
5.3.2b Preliminary Clinical Trial// 
A 74 year-old man was being weaned off the IABP after a mitral valve repair 
operation. The IABP augmentation was reduced in steps of 20% approximately every 
15 minutes and the CO was then measured using Swan-Ganz thermodilution method. 
At 100% augmentation, the patient's CO was 6.01 I/min and when the augmentation 
was turned down to 20%, the CO reduced to 5.5 I/min. The figure below shows the 
patient's SV02 ratio of ratios recorded using the new venous oximetry method at 
different stages of the weaning-off period. 
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Figure 5.3- SV02ratio of ratios at various levels of augmentation during 
weaning off period. 
It can be seen that there was a gradual upward drift of the ratio of ratios as the IABP 
augmentation was gradually reduced. This indicates that there was a decrease in the 
patient's SV02 peripherally when the 
CO was reduced. Although the CO was only 
reduced slightly, from 
6.01 I/min to 5.5 I/min, the new venous oximetry technique 
was still able to detect the slight changes. 
This shows that the new venous oximetry 
technology is sufficiently sensitive to reflect these changes. 
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5.3.3 Design of the Finger Probe 
In the present system, a separate digit cuff is used to modulate the venous system. A 
future design of the instrument would encompass combining the digit cuff with the 
transmission mode finger probe. This would reduce the set up time for the instrument. 
The digit cuff would be made adjustable, both in the circumference and the distance 
from the measurement site so as to cater for fingers of different lengths and sizes. 
Furthermore, the digit cuff would need to be replaceable as the pneumatic cuff will be 
subjected to wear and tear during inflations and deflations. The tube leading to the 
cuff would also need to be combined with the finger probe. All these design 
requirements would pose quite a challenge in designing the new probe. The new 
finger probe could be designed according to the sketch in the figure below. The 
careful design and construction of the probe would lead to a more integrated 
instrument and a shorter set up time for the instrument. 
Adjustable 
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Figure 5.4 - Sketch of the new finger probe 
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5.3.4 Natural Venous Pulsations 
The new method of venous oximetry proposed in this thesis is based on inducing a 
mild perturbation in the venous system by artificially injecting a pulsatile signal into 
it. However there is strong evidence that a natural peripheral venous pulsation of 
central venous origin is presentý811. In a studyý821 by Shelley et al., venous pulsations 
were being recorded using a pulse oximeter as a plethysmographer. The detection of a 
venous pulse with a standard pulse oximeter opens up an intriguing avenue of 
investigation. It should be theoretically possible to determine the peripheral venous 
oxygen saturation by using the plethysmographic information. The feasibility of this 
method of monitoring venous oxygen saturation has never been explored before. 
One of the difficulties in this method would lie in the area of extracting the central 
venous pulsations from other waveforrns in the plethysmograph, which is the product 
of a complex interaction between a number of factors, such as the presence of 
competent venous valves, vascular tone, right heart function, hand position, and 
relative blood volume. Advanced signal processing techniques would need to be 
implemented to extract the signal. The use of the natural venous pulsations to monitor 
venous oxygen saturation would eliminate the use of any artificial pulse generator. 
This natural pulse-based venous oximetry method, if proven to be feasible, would 
expand the functionality of the existing pulse oximeter without any significant change 
in the hardware. This is definitely an area worth looking into in the future. 
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APPENDIX 
This appendix will include the design and implementation of the electronic circuitry 
of the artificial pulse generator. The circuit consists of the air pump circuitry and the 
pinch valve driving circuitry. This section will also include the program listings for 
the micro-controller used to generate the modulation frequency for driving the pinch 
valve as well as the Matlab program listing used to conduct the experiments. 
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ARTIFICIAL PULSEGENERATOR CIRCUITRY & PINCH VALVE 
CONTROLLING CIRCUITRY 
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Figure 1.1 - Schematic for the artificial pulse generator and pincn vaive 
controlling circuitry. 
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This section describes the design and operation of the artificial pulse generator 
circuitry. The circuitry can be divided into two sections, the air pump circuitry and the 
pinch valve driving circuitry. We shall take a closer look at the air pump controlling 
circuitry first. 
1.1.1 Air Pump Controlling Circuitry 
A Digital to Analogue Converter (DAC), MX7224, UI in the circuit diagram is used 
to interface the air pump to the computer via the PLD card. There are 8 data lines 
from the PLD card with an extra line for chip enable. The outputs of these data lines 
are not latched, the DAC register is latched when the chip enable line goes from a low 
to a high. An inverter (74HCT04), U3A in the diagram is used to invert the chip 
enable line such that it could be used for latching the data onto the DAC register. The 
input data has a range from 00 hex to FF hex, 255 steps in total. The DAC is 
referenced with aI OV voltage regulator (MX5 84), U4 in the diagram. The output of 
the DAC is connected to an amplifier (U6) implemented using a non-inverting Opamp 
with a gain of 1.68. The gain is chosen such as to match the maximum voltage that 
could be applied to the air pump at the DAC's full range. The output from the Opamp, 
is then applied across the air pump through a transistor, TIP3 I C, QI in the diagram. 
Using this simple DAC controlling circuitry, the air pump pressure could be 
controlled according to the data at the input data lines. 
Pinch Valve Driving Circuitry 
The pinch valve circuitry is implemented using a microcontroller 
from Microchip 
(PIC12C509), U8 in the diagram, it is programmed to output a square wave 
in a 
frequency of 6.511z. This frequency is the modulation frequency of the artificial pulse 
generator. The output 
from the micro-controller is connected to a buffer (U9) and then 
to a transistor 
(Q2) which acts as a switch to switch on and off the pinch valve 
according to 
the square wave frequency. 
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The pinch valve controlling circuitry is interfaced to the PC via the air pump circuitry, 
the voltage applied across the air pump is connected to a transistor switch (Q3) which 
will switch off the pinch valve when the voltage across the pump is OV. 
The program listing is shown below. 
Title: venous modulation 
File Name: veinmod. asm 
Date: Aug 9,2000 
Processor: PIC12C509 
clock Frequency: Internal 4mhz 
Description: simple program to output a square wave for driving the pinch val 
#include "pl2c5O9. inc" 
BOOTC509 equ 
CounterA equ 
counterB equ 
; counterc equ 
ORG 
Goto 
include standard assembler routines 
OX0000 the 12C509 boots up at address OxOOOO 
H'0007' 
H'0008' 
H'0009' 
0000 
LOAD-OPTION 
; PIC Time Delay = 0.0769230s with osc =4 MHz 
DELAY-ROUTINE movlw 
movwf 
movlw 
movwf 
loop decfsz 
oto 
ecfsz 
goto 
retlw 
LOAD-OPTION MOVLW 
option 
LOAD--TRIS MOVLW 
TRIS 
DO-AGAIN bsf 
CALL 
bcf 
CALL 
GOTO 
END 
D'100' 
CounterB 
D'228' 
CounterA 
CounterA, 1 
loop 
counterB, 1 
looý 
D*O 
OXDF zero bit 5 of option register to 
disable timer 0 clock source 
OX08 define GPIO 0-2,4 &5 as outputs, 3 as input 
GPIO 
GPI0,0 
DELAY-ROUTINE 
GPIO, O 
DELAY-ROUTINF= 
DO-AGAIN 
Figure 1.2 - PIC program listing for generating 6-511z square wave 
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The pIC microcontroller program is a rather simple program which uses a delay 
subroutine to calculate how long a state 'HIGH' or state 'LOW' should be maintained. 
The program starts by outputting a 'HIGH' state at one of the output pins and then it 
calls the delay subroutine which will count down to the required time delay. The 
program then changes the state at the output pin and calls the delay subroutine again. 
By looping this program indefinitely, the output pin will produce a square wave which 
frequency depends on the delay subroutine. 
1.2 MATLAB CONTROL PROGRAM 
As mentioned in Chapter 3, the artificial pulse generator is controlled by the computer. 
The pressure of the air pump, the intensity of the LEDs in the finger probe can be all 
controlled by the computer. A program can be written to control these settings, 
including the sampling rate and the duration of the data acquisition. The Matlab 
program controls the different settings through Dynamic Data Exchange (DDE). All 
the experiments conducted in this research used a variation of the program. 
The program starts by initialising the different settings of the artificial pulse generator. 
The air pressure for the pump, the intensity of the LEDs in the finger probe, the gain 
at the input channels, sampling rate and the duration of data acquisition. 
The data acquisition is activated by enabling the interrupt of the parallel port. 
The 
duration of the data acquisition is determined by the sampling rate and the number of 
data samples required. 
The program listing can be found on the following page. 
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clear; 
' , -I - used f-cr sa-v--ng data (used b-, ' the mat--ix data_. -Iame) 
X=1; 
Y--6; 
r-h=OPer'Plddde; 
st-art-vQltage=173; %set a, -r p,, Lrp p-ressure at I-CO psig, 
POstraessage (ch, 1025,1,147) ; %set P-7:! LED tc -r.:. d range, 
post-raessage (ch, 1025,2,147) ; %set : nfra RE: LED tc mid range. 
postraessage (ch, 1025,3,10) %set --:, :, ece:. -, er fcr RED signal at mid range. 
postmessage (ch, 1025,4,10) %set --n rece-ver fcr infra Red singal at -r. -, a range. post-raessage (ch, 1041,1) ; %set '----;,, el -, -- I. 
postmessage (ch, 1040,1) ; %en-=b, -'e inter-rupt. 
ýcr i=l: l 
tor-al_sample=O; 
postriLessage (cah, 1025,5, start 
- 
voltage); %set air p: essu--e. 
pcst. raessage (ch, 1040,1) ; %enah-le interrupt, 
postmessage(ch, 1044); %cleaý-- buffer. 
while total 
- 
sample<270000 22720,21- 
[d, n]=getdata(r-h, 5000); 
if (n>O), 
Jf (exist(Idatal)), 
data=adddata (data, d) 
total_sa-ruple=total-sam. ple+n; 
else 
ar -or . ples f every a-4-- pressure settin. g. 
data=d; 
tctal_sa-raple=n; 
end; 
end; 
end; 
postraessage(ch, 1025,5,0); %s,:; cp a-r p, -, r-. p.. 
postmessage(ch, 1044); %clear h,. iffeerr. 
post-message(ch, 1040,0); %di3able ýiarrd-, ý; aie :. aterrupt. 
save data0l, data; 
end; 
clear data; 
end; 
clear d; 
postmessage(ch, 1040,1); 
postmes sage (ah, 102 5,5,0) 
postriessage (Gh, 1040,0) ; 
Figure 1.3 - Matlab program 
listing for controlling the Artificial Pulse Generator 
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